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Introduction 
Les troubles émotionnels, tels que la dépression et l’anxiété, sont fréquemment observés chez des 
patients souffrant de douleur chronique, ce qui aggrave singulièrement le pronostic global de ces 
patients (1). Les études chez l’animal permettent de modéliser ces aspects, et notamment 
l’émergence progressive de troubles apparentés à la dépression et à l’anxiété au cours d’états 
douloureux chroniques  (2-4). Certains auteurs suggèrent que la douleur chronique pourrait 
représenter une forme de stress chronique à l’origine de l’apparition des troubles émotionnels (5). 
Cependant, des études récentes montrent que la douleur chronique et le stress chronique ont des 
effets très différents sur l’axe hypothalamo-hypophyso-surrénalien (HHS). Ainsi, l’augmentation 
des niveaux de corticostérone et l’altération du rétro-contrôle négatif contrôlant l’activité de l’axe 
HHS, classiquement observées lors d’un stress chronique, ne sont pas retrouvées dans notre 
modèle de douleur neuropathique, un modéle de constriction du nerf sciatique (modèle du cuff) 
chez la souris (3). 
Selon une autre hypothèse, il existerait des substrats neurobiologiques communs au traitement 
des informations nociceptives et à la régulation des états émotionnels. Ainsi, les modifications 
induites lors de la douleur chronique pourraient perturber les mécanismes de régulation de 
l’humeur et contribuer à l’émergence de troubles dépressifs. En particulier, le cortex cingulaire 
antérieur (CCA) jouerait un rôle primordial à l’interface de la douleur et des émotions (6, 7).  
Afin de mieux comprendre le rôle du CCA dans l’émergence de désordres affectifs lors d’une 
douleur neuropathique chronique, nous avons caractérisé, dans notre modèle murin, les réponses 
somato-sensorielles, aversives et émotionnelles, ainsi que l’activité électrique neuronale de cette 
structure corticale. 
Méthodes 
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Nous avons utilisé un modèle murin de douleur neuropathique, précédemment mis au point par 
notre groupe de recherche (8). Celui-ci est induit par la mise en place d’un manchon de 
polyéthylène (« cuff ») autour de la branche principale du nerf sciatique. Nous avons montré que 
5 semaines après l’induction de la neuropathie, les animaux développent des troubles émotionnels 
apparentés à l’anxiété et la dépression (3). Au cours de ce travail de thèse, nous avons approfondi 
la caractérisation de ce modèle sur une période de 22 semaines, et étudié (i) l’allodynie 
mécanique, en utilisant des filaments de Von Frey, (ii) la douleur spontanée, en utilisant un 
conditionnement de préférence de place (CPP), ainsi que (iii) les comportements de type anxio-
dépressifs à travers une batterie de tests (boîte clair-obscur, test d’hyponéophagie, splash test, test 
de la nage forcée). Afin d’évaluer le rôle du CCA au cours de la douleur neuropathique 
chronique, nous avons réalisé des lésions de cette structure cérébrale par des injections locales 
d’acide iboténique. En parallèle, nous avons également examiné les conséquences 
comportementales d’une stimulation de l’activité neuronale dans le CCA par optogénétique, chez 
des souris naïves génétiquement modifiées (Thy1-ChR2-YFP). Après avoir ainsi démontré 
l’implication essentielle du CCA dans la comorbidité entre douleur neuropathique chronique et 
épisode dépressif majeur, nous avons déterminé, sur une période de 22 semaines, les profils 
d’activité neuronale dans le CCA en réalisant des enregistrements électrophysiologiques unitaires 
in vivo.  
 
Résultats 
Caractérisation des conséquences à long terme de la douleur neuropathique 
Suite à l’induction de la neuropathie l’allodynie mécanique persiste pendant 12 semaines. Elle 
s’accompagne d’une douleur spontanée qui continue de se manifester même après la rémission 
spontanée de l’allodynie, c’est à dire au delà de 12 semaines. Cette douleur spontanée régresse à 
son tour environ 22 semaines après l’induction de la neuropathie. En parallèle, les animaux 
développent à partir de la 5
ème
 semaine un phénotype anxio-dépressif qui se manifeste jusqu’à la 
22
ème
 semaine. 
 
Rôle du CCA sur le phénotype anxio-dépressif induit par la douleur neuropathique 
Nos résultats indiquent que la lésion par l’acide iboténique du CCA bloque l’apparition du 
phénotype anxio-dépressif et de la douleur spontanée chez les animaux neuropathiques, mais 
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n’affecte pas l’émergence de l’allodynie (9). Nous montrons également, par une approche 
optogénétique, que l’inhibition du CCA, bloque les conséquences anxiodépressives de la douleur 
neuropathique et la douleur spontanée. Enfin, chez des souris naïves, en l’absence de douleur 
neuropathique, l’activation des neurones pyramidaux du CCA est suffisante pour induire des 
comportements anxio-dépressifs (9). Ni l’inhibition du CCA en condition neuropathique, ni son 
activation chez des animaux naïfs n’ont d’effet sur le seuil de sensibilité mécanique. 
 
Les conséquences anxio-dépressives de la douleur neuropathique s’accompagnent d’une 
hyperactivité des neurones du CCA 
Afin d’explorer le rôle du CCA au cours de la neuropathie, nous avons mesuré l’activité 
neuronale spontanée à 4 moments clés de la neuropathie. 
Stade1 : les animaux expriment une allodynie mécanique mais n’ont pas encore développé de 
phénotype anxio-dépressif (2-3 semaines après l’induction de la neuropathie). 
Stade2 : les comportements anxio-dépressifs sont apparus alors que l’allodynie est toujours 
présente (6-12 semaines après l’induction de la neuropathie). 
Stade3 : les animaux sont en rémission spontanée de l’allodynie mécanique mais présentent 
toujours des comportements apparentés à l’anxiété et à la dépression (12-18 semaines après 
l’induction de la neuropathie). 
Stade4 : l’allodynie mécanique est absente, et les réponses émotionnelles se sont normalisées (22-
26 semaines après l’induction de la neuropathie). 
Nos résultats indiquent que l’activité neuronale spontanée du CCA est augmentée chez les 
animaux neuropathiques aux stades 2 et 3 par rapport aux animaux contrôles. De plus, l’activité 
en bouffées de potentiels d’action (burst) est également augmentée chez les animaux 
neuropathiques aux stades 2 et 3. Afin d’identifier le type de neurones impliqués dans cette 
augmentation d’activité, nous avons réalisé des marquages juxta-cellulaires et des identifications 
neurochimiques par des marquages par la calbindine, la Cam kinase de type II et la parvalbumine. 
Les résultats indiquent que ce sont les interneurones, ainsi que les neurones pyramidaux du CCA, 
qui présentent une augmentation de leur activité électrique aux stades 2 et 3. 
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Conclusion 
Nos résultats confirment que les composantes sensorielles et émotionnelles, ainsi que les 
conséquences anxio-dépressives, se mettent en place et se développent au cours du temps après 
l’induction d’une douleur neuropathique. Ils montrent également le rôle crucial du CCA, une 
structure corticale de la « matrice douleur » à l’interface de la douleur chronique et des 
régulations émotionnelles. En effet, alors que la lésion du CCA est suffisante pour empêcher 
l’apparition de conséquences émotionnelles négatives chez les animaux neuropathiques, la 
stimulation de cette région corticale est suffisante pour induire des troubles comportementaux 
similaires chez des animaux naïfs. Enfin, nos résultats révèlent une similitude frappante entre la 
cinétique des troubles anxio-dépressifs et celle des modifications de l’activité 
électrophysiologique du CCA. Ces modifications, qui correspondent à une augmentation de 
l’activité unitaire et de l’activité en bouffées de potentiels d’action des neurones pyramidaux et 
des interneurones, se manifestent uniquement lorsque les troubles thymiques comportementaux 
sont présents. 
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Preface 
Neuropathic pain is a chronic condition that arises as a consequence of a disease or a lesion 
affecting the somatosensory nervous system (10). Chronic pain affects approximately 30% of the 
population, where as neuropathic pain is present in around 8 % of the population (IASP). 
Neuropathic pain can have dramatic consequences for patients (11). Thirty-four percent of 
neuropathic pain patients develop mood-disorders (12) which dramatically disrupt patients’ 
quality of life (1).  
The most frequently observed mood disorders in chronic pain patients are generalized anxiety 
and major depressive disorders The Diagnosis and Statistical Manual of Mental Disorders V 
(DSM-V) criteria for generalized anxiety disorder include the presence of excessive anxiety and 
worry that lasts at least 6 months and have at least 3 symptoms of the following: edginess or 
restlessness, tiring easily, impaired concentration, irritability, increased muscle aches or soreness 
and difficulty sleeping. The DSM-V criteria for major depression disorder include having a 
depressive episode for at least 2 weeks and at least 5 of the following symptoms: depressed 
mood, loss of interest or pleasure in almost all activities, a weight loss or gain, sleep disturbances, 
agitation or motor retardation, fatigue, feelings of worthlessness or guilt, difficulty concentration 
and thoughts of death and suicide. 
This thesis explores the underlying processes of the neuropathic pain and depression 
comorbidity by using the sciatic nerve cuffing model of neuropathic pain. We characterize the 
development of the somatosensory and aversive consequences of neuropathic pain as well as 
anxiodepressive-like behavior. Additionally, we perform electrophysiological single-unit 
recordings from the ACC, a region implicated in both pain related and mood related processes, 
and manipulate its activity through optogenetic excitation and inhibition. 
In the next introductory chapters we will provide information on pain (I), neuropathic pain 
(II), the methods of preclinical modeling of neuropathic pain-induced mood disorders (III) and 
preclinical insights of neuropathic pain-induced mood disorders (IV).  We will finish the 
introduction with a draft of the, as of yet unpublished, review which describes the ACC’s 
connectome, role in mood processing and in pain processing (V). The introduction will be 
followed by two research papers, one of which is published in Biological Psychiatry (VI-VII), 
and the general discussion (VIII).  
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Introduction 
I. Pain 
The International Association for the Study of Pain (IASP) defines pain as an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage. This definition 
suggests the importance of both sensory and emotional components of pain. In addition, in 1968, 
Melzack and Casey (13) suggested that the pain experience reflects the interaction of 
somatosensory, affective and cognitive processes which introduced for the first time the notion of 
pain matrix. Since, this concept is improved thanks to functional imaging studies and now the 
pain matrix defines a group of brain regions that take part in the processing of pain information 
such as the posterior insula, parietal operculum, mid-cingulate, the primary sensory/motor areas, 
anterior insula, ACC, dorsolateral prefrontal cortex, posterior parietal cortex, perigenual 
cingulate, orbitofrontal cortex, anterolateral prefrontal cortex and the ventral striatum (14).  
 According to this new pain matrix concept, pain processing occurs in three steps 
including the processing of nociceptive information, the translation of nociceptive information to 
pain experience and, finally, the formation of pain memory. Neurons from spinal laminae I, V 
and VII convey nociceptive information from the periphery to the posterior, centrolateral, 
mediodorsal and posterior nuclei of the thalamus (15, 16), forming what is called the 
spinothalamic system. These regions synapse unto cortical areas responding to noxious stimuli 
such as posterior insula, medial parietal operculum and mid-cingulate cortex and somatosensory 
cortices (17-20).  
 The transition of nociceptive information to the conscious pain experience is mediated by 
the mid and anterior insulae, the ACC, the prefrontal and posterior parietal areas; with less 
consistency, the striatum, supplementary motor area, the hippocampus, the cerebellum, and the 
temporoparietal junction. Mid and anterior insulae are responsible for the posterior to anterior 
information flux within the insula, which supports the transformation of sensory events into 
vegetative reactions and associated internal feelings (14, 21). The cognitive section of the ACC, 
the prefrontal and posterior parietal areas, are thought to be involved in attention, anticipation 
learning and cognitive control (14).  
 Lastly, third order networks, constitute by the perigenual cingulate, the orbitofrontal 
cortex, the temporal pole, and the anterolateral prefrontal areas, are implicated in both pain 
13 
memory and the emotional components such as unpleasantness of pain (22, 23). These regions 
are also involved in the generation of subjective pain experience by observations of other 
people’s suffering, or the pain-relieving effects derived from placebo (24, 25) or strong religious 
believes (26). Such changes are not elicited by affecting sensory gain but by reevaluation and 
interpretation of the meaning of a stimulus.  
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II. Chronic Neuropathic Pain
Pain normally serves to direct behavior towards self-protection and promotes adaptive behavior 
(27) but when pain becomes chronic, it loses its adaptive and biologic function of signaling injury 
or disease. Chronic pain affects the lives of 20-60% of the world population (28, 29) and remains 
difficult to treat (30). Among different types of chronic pain such as inflammatory, 
musculoskeletal, visceral, in this study, we mainly focused on neuropathic pain.  Neuropathic 
pain is caused by a lesion or disease affecting the somatosensory system (IASP; (31). Depending 
on whether damages affect the peripheral or central nervous system, neuropathic pain can be 
further divided into central neuropathic pain and peripheral neuropathic pain (32). For most 
patients, neuropathic pain has a peripheral origin, arising as a consequence of peripheral nerve 
injury or as a consequence of a metabolic disease such as diabetes. Nerve injuries and diabetic 
peripheral neuropathy account for almost two-thirds of the patients. However, neuropathic pain 
can also result from infectious diseases, as in post-herpetic neuralgia, from exposure to 
neurotoxic compounds, such as those used for cancer chemotherapy (32, 33). Causes arising from 
the central nervous system include spinal cord injury, multiple sclerosis, Parkison’s disease and 
stroke related lesions (32, 33). Diagnosis of neuropathic pain is often based on physical 
examination and questionnaires that assess the characteristics of neuropathic pain (33-35). 
Symptoms include spontaneous pain, allodynia, hyperalgesia, paresthesia, dysaesthesia and 
hypoesthesia (32, 33) (Box 1).  
According to clinical and preclinical studies (36-38), the physiopathology of neuropathic 
pain lies in peripheral, at the level of the nerve and dorsal root ganglia, and central mechanisms, 
at level of spinal cord and brain (36-38). As the central nervous system is the primary topic of 
this thesis work, we discuss the most studied central nervous system modifications in the next 
section.   
A. Central modifications 
One of the consequences of nerve injury is the sensitization of the central nervous system which 
is associated with the development and maintenance of chronic pain. The nervous system goes 
through a process called “wind-up”, when central sensitization occurs, and gets regulated in a 
persistent state of high reactivity. This state of reactivity subsequently maintains pain sometimes 
even after the initial injury has healed. Sensitization of the central nervous system can be caused 
by a disrupted inhibitory/excitatory balance and plasticity changes in the spinal cord or brain.  
Box 1.  IASP definitions of neuropathic pain symptoms  
Hyperalgesia: increased pain from a stimulus that normally provokes pain 
Allodynia: painful response to a normally non-painful stimulus 
Paresthesia: abnormal sensation whether spontaneous or evoked 
Dysesthesia: unpleasant abnormal sensation, whether spontaneous or evoked 
Hypoesthesia: decreased sensitivity to stimulation, excluding special senses  
15 
Inhibitory/excitatory imbalance 
Disrupted inhibitory/excitatory balance has been observed at both the spinal and supraspinal level 
in chronic pain conditions (39-45). One of the reasons for this imbalance is the decrease of 
inhibitory activity. For instance, the loss of inhibition in the dorsal horn by a reduction of GABA-
induced inhibitory postsynaptic currents (IPSCs) (39, 40), reduced GABA receptor subunit 
expression (41), loss of interneurons (42) and calcium-channel subunit upregulation (43) lead to a 
decrease in firing thresholds contributing to mechanical and cold allodynia (42, 44, 45) as well as  
hyperalgesia (44) observed in neuropathic pain. At the supraspinal level, clinical studies have 
shown that glutamate levels were higher, and GABA levels lower in the posterior insula (46) in 
neuropathic patients. Additionally animal studies have shown disinhibition of ACC layer V 
pyramidal neurons (47) and disinhibition in the central nucleus of the amygdala due to a decrease 
of GABAergic inhibition (48) in neuropathic pain animal models.  
Spinal and supraspinal plasticity changes in neuropathic pain 
In neuropathic pain conditions, both functional (49-52) and morphological (53-55) plasticity 
changes are observed at the spinal and supraspinal level. A major driving force in initiating 
change in synaptic strength is the increase of postsynaptic calcium levels. Ionotropic receptors 
and voltage-gated calcium channels as well as calcium release from intracellular stores can 
increase calcium influx (56, 57) which in turn induces cellular changes that increase synaptic 
strength (58). For instance, in the spinal cord calcium influx has been shown to activate 
extracellular signal-regulated kinase (ERK) which in turn has been shown to increase AMPA and 
NMDA receptor insertion into the membrane (59). Indeed, dorsal horn AMPA (60) and NMDA 
receptor (52) expression were found to be increased in an animal models for neuropathic pain 
(52) and increased NMDA receptor trafficking has also been reported (54). 
Synaptic plasticity changes within cortical areas involved in pain processing has been 
observed in chronic neuropathic pain (61). For instance, nerve injury induced synaptic 
remodeling by synaptogenesis, synapse elimination, strengthening of persisting synapses and 
hyperexcitability have been shown in the somatosensory cortex (53). Besides alteration in 
synaptic transmission, long term potentiation (LTP) and depression (LTD) are forms of plasticity. 
LTP and LTD may also be altered in chronic pain conditions. However, alterations in LTP/LTD 
may be different depending on the brain region. For instance, a reduction in hippocampal LTP 
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without affecting LTD has been found in neuropathic pain (62, 63) but LTP increase was 
reported in the ACC (49-51).   
An in vivo study showed that digit amputation leads to long-lasting membrane potential 
depolarization in ACC neurons of adult rats (51). In mice with peripheral nerve ligation, it has 
been shown that pyramidal neurons in layer II/III of the ACC have an increase of AMPA-
receptor-mediated excitatory postsynaptic currents (EPSCs) (49), of membrane AMPA GluA1 
receptors (50) and of NMDA GluN2B receptors (51), all of which lead to postsynaptic 
enhancement. In addition, presynaptic release of transmitters is enhanced in the ACC. Paired-
pulse facilitation, a transient form of plasticity and a way to test presynaptic functioning, showed 
a significant reduction in ACC neurons in neuropathic mice which indicates presynaptic 
enhancement of excitatory synaptic transmission after nerve injury (49). Increased excitatory 
transmission has also been observed in other brain regions, such as the amygdala (64), insular 
cortex, and primary and secondary sensory cortices (65). 
 
Central nervous system activity changes 
Cortical activity abnormalities are a common finding in neuropathic pain. However, because 
different subregions have profoundly different functional roles, there are some discrepancies 
between studies. However, cortical hyperactivity has been reported in the presence of neuropathic 
pain most frequently. For instance, an EEG study showed hyperactivity within the theta and beta 
frequency range originating from the IC, ACC and somatosensory cortices in patients with 
ongoing neuropathic pain (66). Similarly a PET study reported hyperactivation in ongoing 
neuropathic pain in the anterior insula, posterior parietal, lateral inferior prefrontal, and the ACC 
(67). Apart from changes in spontaneous activity, hyperactivity during heat allodynia has also 
been reported. An fMRI study showed that the bilateral anterio insula, right ventral putamen, 
orbital frontal cortex, right dorsolateral prefrontal cortex and the ACC are hyperactive during 
heat allodynia in neuropathic patients(68).  
On the other hand, cortical hypoactivity has also been reported. For instance, the 
ventromedial PFC, an important region for the integration of cognitive and emotionally relevant 
information (69, 70), has been shown to be hypoactive in neuropathic pain (24, 71, 72). From this 
region connections trigger inhibition of pain signals via the periaqueductal grey (14). This notion 
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is supported by the findings that analgesic procedures, such as distraction and motor cortex 
stimulation, trigger ventromedial PFC activity (73, 74). 
In neuropathic pain patients, another common finding is thalamic hypoactivity (14), 
which is thought to be a compensatory mechanism of functional reorganisation after nerve 
damage, however, analgesic procedures restore thalamic blood flow without alleviating pain 
relieve (75-77), and blood flow is not correlated with pain relief (78). Another common finding is 
an increase of neuronal bursting and electroencephalographic slowing in the thalamus of 
neuropathic pain patients (14) which is thought to be caused by thalamic cell hyperpolarisation 
(14). 
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III. Preclinical modeling of neuropathic pain induced mood disorders
Besides somatosensory alterations, neuropathic pain can also induce mood disorders. For 
instance, the prevalence rate for major depressive disorder is about 30% in neuropathic pain 
patients (1, 12). While the comorbidity between neuropathic pain and mood disorders are well 
established the underlying mechanisms remain unclear. For this purpose, animal studies are 
needed to model the comorbidity between neuropathic pain and mood disorders. 
Models of neuropathic pain in rodents can be based on peripheral nerve injuries, central 
injuries, trigeminal neuralgia, diabetic neuropathies, chemo-induced neuropathies, postherpetic 
neuralgia, and so forth (79-82). While many neuropathic pain models have been developed in 
rodents (79-82), most of the peripheral neuropathic pain models rely on ligation, compression or 
partial sections of the sciatic nerve (Table 1). This nerve is of easy access and nociceptive tests 
can be easily conducted on hind paws. These models rely on three or four loose ligatures around 
the main branch of the sciatic nerve (chronic constriction injury, CCI) (83), on the tight ligation 
of the sciatic nerve (partial sciatic nerve ligation, PSL) (84) or of the L5 and L6 spinal nerves 
(spinal nerve ligation, SNL) (85), on the ligation of the common peroneal nerve (86), or on the 
implantation of a polyethylene cuff around the main branch of the sciatic nerve (8, 87). The 
spared nerve injury (SNI) is another frequently used model, for which two of the three terminal 
branches of the sciatic nerve are tightly ligated before their distal axotomy (88). A shared feature 
of these models is to induce mechanical allodynia, as well as changes in thermal sensitivity for 
most of them. 
In this study, we used a sciatic nerve cuffing model which is a reliable and stable method 
to induce neuropathic pain in mice (3). It entails the cuffing of the main branch of the sciatic 
nerve with a polyethylene tube. This standardized procedure results in neuropathic pain with low 
inter-individual variability for long lasting mechanical allodynia.  
Almost all of the preclinical studies on the anxiodepressive consequences of neuropathic 
pain were performed on models related to sciatic nerve manipulation, using either nerve 
compression or section. While, some studies failed to show the relationship between neuropathic 
pain and anxiodepressive-like behavior in animals (89-93), other studies did report such 
behavioral phenotypes in neuropathic rodent models (3, 4, 8, 94-98).  An explanation for this 
discrepancy might lie in the timing of the behavioral test after pain induction, since the studies 
showing negative results were performed only 3 weeks after peripheral nerve surgery. Some 
ALB: Anxiety-like behavior, BB: Burrowing behavior, BT:Burying test, CCI: Chronic construction injury, 
DLB: Depression-like behavior, EPM: Elevated-plus maze, EZM: Elevated zero maze, 
FST: Forced swimming test, LD: Light-dark test, MB: Marble burying, NSF: Novelty-suppressed feeding, 
OF: Open eld, SI: Social interaction, SNI: Spared nerve injury, SNL: Spinal nerve ligation, 
SNT: Spinal nerve transfection, SP: Sucrose preference, PSNL: Partial sciatic nerve ligation, 
TST: Tail suspension test.  
Pain Model Species Test Results References
PSNL Rat BT BB deﬁcits Andrews et al., 2012
Mouse OF, EPM, TST No eﬀect     Hasnie et al., 2007b
Mouse OF No eﬀect     Kodama et al., 2011
Mouse LD, EPM ALB              Narita et al.,2006a,b
Mouse LD, EPM ALB Matsuzawa-Yanagida et al., 2008
SNL Rat OF, EPM,LD, FST No eﬀect     Kontinen et al., 1999
Mouse OF, EPM, LD, FST ALB, DLB Suzuki et al., 2007
CCI Rat FST, SP No eﬀect Bravo et al., 2012
Rat FST, OF DLB Zeng et al., 2008
Rat EPM ALB Roeska et al., 2009
Rat FST DLB Fukuhara et al.,2012
Mouse EZM, FST, OF no eﬀect      Urban et al., 2011
SNI Rat OF, EPM,FST no ALB, DLB Gonçalves et al., 2008
Rat OF, EPM, FST ALB, DLB Leite-Almeida et al., 2009
Rat FST, SP DLB             Wang et al., 2011
Mouse OF, FST no ALB, DLB Norman et al., 2010
Mouse EZM, FST, OF no eﬀect Urban et al., 2011
Mouse DL,NSF ALB Mutso et al., 2012
Cuﬀ Mouse EPM, MB, SI, TST ALB               Benbouzid et al., 2008
Mouse LD, MB, NSF, Splash, FST ALB, DLB      Yalcin et al., 2011
SNT Rat FST DLB               Hu et al., 2010
Rat BT BB deﬁcits Andrews et al., 2012
Antiretroviral Rat OF,BT ALB, BB deﬁcits Huang et al., 2013
Table 1. Summary of studies on the aective consequences of neuropathic pain (from Yalcin et al., 2014). 
Rat OF, EPM ALB Seminowicz et al., 2009
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studies show that anxiodepressive behavior develops over time with anxiety-like behavior 
developing only after 4 weeks after neuropathic surgery and depressive-like behavior becoming 
apparent between the 6
th
 and 8
th
 week after neuropathic surgery (3). Other factors such as species, 
strains of animals, the type of pain surgery and the time of day the tests are performed may also 
influence the results (99-101). 
In order to study the anxiodepressive consequences of neuropathic pain a variety of tests 
are used. Most of these tests evaluate anxiety-related behavior by measuring exploration 
behavior, such as the elevated plus maze, the open field or the dark-light exploration test (3, 94, 
102). The novelty-suppressed feeding test, measures the conflict between the drive to eat and the 
fear of venturing into the center of the open field. This test has been used to assess 
anxiodepressive-like behavior since it has been shown to respond to chronic antidepressant drug 
treatment (103). Other behavioral tests consist of exposing the animal to stressful situations and 
measure stress coping, such as the forced swimming and the tail suspension tests (3, 91). Aside 
from mood, the animal’s interest in pleasurable activities such as consuming sucrose solution or 
engaging in social interactions can also be tested both of which are decreased in neuropathic pain 
(8, 104). Burrowing, an evolutionarily conserved behavior that likely reflects motivation and 
general well being, can also be used to test the consequences of neuropathic pain and has been 
shown to be reduced in neuropathic animals (105).  Chronic pain (106, 107) and depressed 
patients (108) frequently show sleep related issues such as insomnia or hypersomnia. Animal 
studies have confirmed this by investigating the effect of chronic pain on sleep efficiency, 
arousals (109), wakefulness and non-rapid eye movement (NREM) sleep (110, 111) showing that 
wakefulness is increased and sleep is impaired. Neuropathic animals, have been found to show 
cognitive impairment including; impaired attention (101) but also memory deficits such as altered 
working memory (62, 112), short term memory (62)  and spatial memory (101). For this thesis, 
we used a battery of tests to evaluate anxiety and depressive-like behavior which will be 
explained in more detail in chapter VI and VII. 
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IV. Mechanisms of neuropathic pain-induced mood-disorders:  
Insights from animal studies 
Clinical studies have shown both morphological and functional changes in brain structures 
including the medial prefrontal cortex (mPFC) (113-115), the ACC, the hippocampus (116, 117), 
the amygdala (118) and the thalamus (119, 120) in neuropathic pain induced affective and 
cognitive disorders (Fig. 1). As the ACC has been implicated in many mood-disorders and is the 
main subject of this thesis, we decided to dedicate chapter 3 to this structure. 
 
Neuroanatomical and plasticity changes 
The somatosensory, anterior cingulate and the insular cortex mediate and modulate pain 
processing (14). While the somatosensory cortex plays a role specifically in discriminating the 
location and intensity of painful stimuli (115), it has no direct implication in affective, 
motivational and cognitive information of the pain.  
The hippocampus plays a major role in learning and memory (121, 122), in addition, it 
has been shown to be responsible for cognitive consequences of neuropathic pain (123, 124) such 
as deficits in working memory (62, 101), short-term memory (62) and recognition memory (92). 
In both neuropathic patients and animals, hippocampus volumes were decreased which was 
associated with a reduction of neurogenesis in the dentate gyrus (116). Nerve injury has also been 
shown to reduce presynaptic terminals density at CA3-CA1 synapses (62) and was correlated 
with impaired contextual fear extinction (116) and memory deficits (62). Additionally, chronic 
pain-induced hippocampal plasticity changes include the induction of LTP in the dentate gyrus, 
CA1-CA3 synapses (62, 63).  
The central (CeA) and baseloteral amygdala (BLA) play important roles in the affective 
and cognitive aspects of pain (125-128). For instance, amygdala morphological analyses showed 
an increase of amygdala volume in animals with spared nerve injury displaying anxiodepressive 
behavior, which was associated with increased neurogenesis in the CeA and the BLA (94). 
Additionally, another study showed that CeA neuron excitability was increased and BLA-CeA 
synapses were potentiated (129). This suggests that NMDA receptors, by facilitating BLA inputs 
or synaptic signaling between CeA interneurons, help maintain neuropathic pain (130).The 
GABAergic system (131) also plays a role in facilitating neuropathic pain. GABA-A receptors in 
the CeA can modify avoidance behavior under the influence of pharmacological manipulation in 
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Nucleus accumbens:
Hippocampus: 
Fig. 1 Summary of functional and morphological alterations in animal with neuropathic pain (
From Yalcin et al., 2014.)
ACC: Anterior cingulate cortex, AR: Adrenoceptor, BDNF: Brain derived neurotrophic factor, 
CRF: corticotropin releasing factor, D: Dopamine, 
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neuropathic animals which shows the CeA’s role in affective processing under the influence of 
neuropathic pain (131).  
The mesolimbic pathway, including the ventral tegmental area (VTA) and the nucleas 
accumbens (NAc) have been related to depression and its treatment (132, 133). These regions 
have been found to respond to aversive and nociceptive stimuli (134, 135) and increased 
functional connectivity between the NAc and the PFC was related to the transitioning of acute 
pain into chronic pain (136). GluA1 subunits of AMPA glutamate receptors in NAc synapses are 
increased in rodents with neuropathic pain (137). These changes underlie anxiodepressive-like 
behavior as the blockage of AMPA receptors increased depression-like behavior in neuropathic 
animals (137). 
 
Neuroendocrine parameters 
Mood disorders are frequently associated with HPA-axis changes (138). However, such 
alterations do not seem to be prevalent in the context of neuropathic pain. Corticosterone 
hormone levels are not changed in rats 3 weeks after nerve constriction injury (139, 140). This is 
further supported by previous results from our team showing no corticosterone level alterations 
during basal or stress conditions until 8 weeks after peripheral nerve compression (3). It seems 
that, even though neuropathic pain leads to similar behavioral consequences as chronic stress, 
sustained neuropathic pain differs from chronic stress concerning the neuroendocrine response.  
Another point of interest are thyroxine (T4), free thyroxine (fT4), triiodothyronine(T3) 
and thyroid stimulating hormone (TSH) levels after nerve ligation. Decreased plasma levels of 
T4, fT4 but not T3 and TSH have been found in nerve-injured rats that display decreased social 
dominance behavior towards intruders (141).  
 
Neuroimmune response 
Neuroimmune alterations are shown to play a role in the generation of depression (142, 143) and 
chronic pain (144). The implications of different actors are time-dependent, in which early phases 
of neuropathic pain are characterized by an increase in microglial staining in the periaqueductal 
grey and the hypothalamus (145) and astroglial activation in the periaqueductal grey and 
cingulate cortex is observed during the late phase (146, 147). In the neuropathic pain condition 
IL-1β, a proinflammatory cytokine involved in the maintenance of neuropathic pain (148), is 
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upregulated in the brainstem (119), the PFC (119) and the hippocampus (149). In addition, IL-6 
levels (150) and Nuclear Factor kappa B  expression, a transcription factor involved in the 
immune response (151) are elevated in the hippocampus. In turn, these changes have been shown 
to be related to the generation and maintenance of LTP, since LTP can increase the expression of 
IL-1 β and IL-6 (152, 153) whereas blocking them can impair or prolong LTP maintenance, 
respectively (152, 153).  
 
Neurotrophic factors 
Alterations in neurotrophic factors, such as brain-derived neurotrophic factor (BDNF) are also 
found to contribute to depression and antidepressant treatment effect (154). BDNF, besides 
regulating neuronal survival and differentiation, has been found to participate in activity-
dependent synaptic plasticity mechanisms (155, 156). BDNF decrease has been shown in the 
hippocampus of depressed patients (157) while antidepressant treatment activates the BDNF-
signaling pathway (138). In the spinal cord, BDNF is found to participate in neuropathic pain 
pathogenesis by causing disinhibition of pain-transmitting signals (158, 159). In the cingulate 
cortex, striatum and the hippocampus BDNF levels are decreased whereas nerve growth factor is 
increased in these regions (150). Supporting these findings is a study that showed that 
administration of 4-methylcatechol, a BDNF synthesis promoter, suppresses neuropathic pain-
induced depression (160). However, since few studies investigate the role of BDNF in 
neuropathic pain-induced depression, further work is needed to provide conclusive evidence. 
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V. The Anterior Cingulate Cortex 
The next chapter contains an early draft of a yet unpublished review that we are about to finalize. 
This paper was prepared in collaboration with Clementine Fillinger, who wrote the neuroanatomy 
section and Florent Barthas, who reviewed the ACC’s involvement in pain. The sections on the 
ACC’s involvement in emotional processing and mood-disorders as well as the 
electrophysiological properties of the ACC have been written by me. 
 
A. Multifaceted role of Anterior Cingulate Cortex:  
Insight from emotional and pain studies.  
Over the past 20 years, clinical and preclinical studies depicted the anterior cingulate cortex 
(ACC) as a site of interest for many neurological and psychiatric conditions. The ACC plays a 
critical role in emotion, autonomic regulation, pain processing, attention, memory, decision 
making and visuospatial orientation, as evidenced through imaging, lesion, single-neuron 
recording and electrical stimulation approaches.  
In 1878, Broca described the cingulate cortex as a component of the limbic lobe. Ever 
since, knowledge of this structure expended greatly, and today it is considered as a heterogeneous 
structure, composed of subdivisions with different cytoarchitecture, connections and functions. 
However, whether emotion, cognition and pain processing are segregated according to distinct 
connectomes or subdivisions within the ACC, is still an ongoing debate (69, 161). For instance, 
the hypotheses that the dorsal ACC is only involved in cognitive functions while emotional 
information is processed by the ventral ACC (162), or that the anterior part is an “executive” 
region whereas the posterior region is “evaluative”(163) are no longer supported by recent studies 
(162, 163). 
The primary aim of this review is to compile recent information on the impact of the ACC 
in emotional and pain processing, as well as in their related pathologies, by offering a synthesis 
of both preclinical and clinical data. We will also discuss the influence of cognitive functions on 
this processing. While preparing this review, we deemed it necessary to also offer a comparison 
of the ACC neuroanatomical organization across species, by comparing human, non-human 
primates and rodents. Indeed, a few contradictory reports concerning the ACC under 
physiological and pathological conditions may be reconciled by taking the distinct roles of ACC 
subregions into consideration.   
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B. The neuroanatomy of the ACC 
In primates, the cingulate cortex belongs to the medial wall of the prefrontal cortex, spanning 
from the supracallosal to cingulate sulcus. Along the anteroposterior axis, four subregions 
including the anterior (ACC), the middle (MCC) and the posterior (PCC) cingulate cortices as 
well as the retrosplenial (RS) cortex compose this sulcus (6, 164, 165). Comparison studies based 
on the cytoarchitecture and the homology with the primate cingulate cortex describe only the 
ACC, the MCC and the RS in rodents. Interestingly, no region analogous to the primate PCC was 
found yet (165). The ACC, an agranular structure since it lacks a true layer IV, is composed of 
areas 24, 25, 32 and 33 both in primate and rodent. The MCC is composed of areas 24’, 32’ and 
33’, while the PCC and the RS respectively cover the areas 23, 31 and areas 29, 30. In each 
species, these areas are divided into additional subdivisions (Fig. 2A). Importantly, the rodent's 
cingulate cortex lacks the sulcal areas found in primates.  
This review mainly focuses on the ACC, and more specifically on area 24 which contains both 
neurons and interneurons distinctly distributed in terms of density over different layer and 
subdivisions (166). While there are far more glutamatergic (Glu) neurons (around 80%) than 
GABAergic neurons in all ACC layers except in layer 1, the latter includes heterogeneous 
subpopulations based on calcium binding proteins (parvalbumin (PV), calbindin or calretinin) 
and peptides, such as somatostatin (SOM) (167).  
Until the 4
th
 edition of the Paxinos and Franklin's “the Mouse Brain in Stereotaxic 
Coordinates” (2012), different nomenclatures were used to describe the ACC in rodents, making 
comparisons with primates confusing (Fig. 2B). In earlier atlases of the rodent brain (168, 169), 
areas 24b/24b' and 24a/24a' were respectively labeled cingulate cortex Cg1 (dorsal) and Cg2 
(ventral) according to Zilles and Wree (170, 171). Thus, the term “anterior cingulate cortex” has 
been often employed to refer to Cg1 and Cg2, even if areas 24a’ and 24b’ actually belong to the 
MCC and not to the ACC (165). A second source of confusion was due to the concept of medial 
prefrontal cortex in rodents (mPFC), constituted by the infralimbic cortex (IL), prelimbic cortex 
(PrL), "anterior cingulate cortex" (Cg or ACC) and of the secondary motor cortex (M2) (172, 
173). Since the IL and the PrL actually correspond to the ACC areas 25 and 32 respectively 
(165), the concept of four structures constituting the mPFC seems inaccurate. To overcome this 
confusion and to favor inter-species comparisons, the latest revision of the rat (174) and mouse 
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(175) brain atlases replaced the terms IL, PrL, Cg1 and Cg2 with their corresponding 
Brodmanns’ area (Fig.2B). 
 
C. ACC connections: insights from rodent and non-human primate studies 
Inputs 
Areas 24a/24b of the ACC receive strong inputs from cortical and thalamic regions, as well as 
from a few other forebrain structures and from a limited number of brainstem centers (Fig. 3A). 
At cortical level, besides strong interconnection linking 24b and 24a, the ACC receives 
moderate to strong inputs from frontal regions, especially from the IL, the PrL and the orbital 
cortices, in both rodents (176, 177) and monkeys (178, 179). More caudally, the ACC receives a 
prominent input from the RS, the parietal associative and the secondary visual cortices (173, 176, 
177, 180). A slight afferent coming from primary sensory areas in mice (181), rats (173, 177, 
180, 182) and monkeys (179, 183) has also been described. Additionally, the hippocampal 
formation and parahippocampal region moderately participate to ACC inputs in rodents (177, 
181, 184) and monkeys (179, 185).  
A second major input to the ACC originates from the thalamus, mainly from the anterior 
nuclei and the lateral parts of the mediodorsal (MD) nucleus, but also from the dorsal, midline 
and intralaminar nuclei in rodents (173, 177, 182, 186-190) and monkeys (183, 185, 191). An 
interesting difference is present between rats and monkeys, with the major thalamic projection 
arising from the anterior thalamic nuclei in rats, especially the anteromedial nucleus, while this 
projection to areas 24a/24b has been described as minor or almost absent in monkeys (191, 192). 
Most of the midline and intralaminar nuclei contribute to a moderate projection to the ACC, with 
a denser projection from the ventral midline nuclei (reuniens and rhomboid) than the dorsal 
midline nuclei (paraventricular and paratenial), in both rats (177, 182, 186-188, 193) and 
monkeys (183, 185, 191).  
A few additional forebrain regions contribute to ACC afferents. The basolateral nucleus of the 
amygdala (BLA) and the claustrum (Cl) project heavily to the ACC in rodents and monkeys (173, 
177, 181, 190, 192, 194-196). Interestingly, the claustro-cingulate connection is bilateral with an 
ipsilateral preference in rats, but is exclusively ipsilateral in mice (181, 196, 197). Additionally, 
the cholinergic corticopetal system, especially the diagonal band of Broca, the medial septum and 
the nucleus basalis, send efferents to the ACC in rats (173, 177, 198) and monkeys (183, 199). 
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Hypothalamic inputs to the areas 24b/24a appear mostly modest, arising mainly from the lateral 
hypothalamic area and from the supramammillary nucleus, in rats (173, 177) and monkeys (183, 
200). 
The ACC receives inputs from brainstem’s monoaminergic centers, in both rats and monkeys, 
arising from the substantia nigra, pars compacta (SNc), the ventral tegmental area (VTA), the 
median and dorsal raphe nuclei (MnR, DR), and the locus coeruleus (LC) (173, 177, 183, 198, 
201, 202). Additional minor inputs have been described from the interpeduncular nucleus, the 
parabrachial nucleus, the mesopontine reticular formation, the area prerubralis and the 
periaqueductal gray in rats (173, 177, 198) and monkeys (183, 201, 203).  
Outputs 
Almost all cortical connections of areas 24b/24a are reciprocal. Indeed, substantial ACC outputs 
have been described to the orbital, the sensorimotor and the visual cortices, the RS, and in 
temporal areas such as the insular, piriform and entorhinal cortices in rats (173, 176, 180, 204, 
205) (Fig. 3B). The hippocampus is a notable exception: it doesn't receive any input from the rat 
ACC (173, 204). In monkeys, projections to motor and premotor cortices have been described 
(205-207), as well as to the presubiculum and to CA1 (205, 208). 
Similarly, the thalamic nuclei, receiving inputs from the ACC, are generally the same as the 
ones projecting to it (173, 190, 209). The stronger thalamic outputs of the rat ACC target the 
anteromedial, the interanteromedial and the lateral part of the MD, and the ventromedial and the 
reuniens/rhomboid nuclei (190, 209-211). In monkeys, a moderated projection to the pulvinar has 
also been reported (185, 212-215). 
In subcortical regions, efferents from the ACC target the BLA and the Cl in rats (173, 204, 
210, 216) and monkeys (185, 195, 208, 215, 217, 218). Contrary to the dominant ipsilateral 
claustro-ACC projection, the ACC-Cl connection is preferentially controlateral (196). The 
cholinergic diagonal band of Broca is also a recipient of areas 24b/24a axons, especially its 
horizontal limb (173, 204). A unidirectional cortico-striatal projection from the ACC targets the 
dorsal striatum, mainly the medial and intermediate parts of the caudate putamen, but only 
marginally projects to the ventral striatum in rats (173, 204, 210, 219). The ACC projection to the 
hypothalamus is mainly directed to the lateral and the posterior hypothalamus (173, 204, 210). 
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In the brainstem, area 24b/24a axons terminate in monoaminergic centers such as the DR, the 
VTA, the SNc and the LC in rats (173, 204, 210, 215). In addition, the rat ACC also projects to 
brainstem centers from where it doesn't receive a major afferent, such as the dorsolateral column 
of the periaqueductal gray (173, 204, 210, 215, 220) and the superior colliculus (221). Other 
efferents have been described to the rat pontine nuclei, the midbrain reticular formation and the 
nucleus of the solitary tract (210, 222), including to a recently defined mesopontine structure: the 
tail of the VTA (tVTA) also named rostromedial tegmental nucleus (RMTg) (223, 224). Finally, 
ACC neurons have been found to project to the cervical and the thoracic spinal cord (210, 225, 
226). In monkeys, efferents to the brainstem have been identified in similar targets, including the 
SNc, the VTA, the dorsolateral part of the periaqueductal gray, the midbrain reticular formation, 
the red nucleus, the DR and the LC (207, 212, 227-229). Regarding the spinal cord, monkeys’ 
cingulospinal projection originates preferentially from the MCC in contrast to the rat ACC (165, 
230). 
 
D. ACC electrophysiological properties 
Eighty percent of ACC neurons are pyramidal cells which function through glutamate (231). 
Glutamate receptors such as AMPA, kainate and NMDA receptors are all found throughout the 
ACC (232, 233). It has been shown that AMPA and kainate receptors are responsible for fast 
synaptic responses (232, 233) whereas NMDA receptors mediate slow synaptic responses in mice 
(234, 235). AMPA receptor density is highest in the supragranular layer with local maxima in 
layers II and III whereas NMDA receptors are present in low quantities with minima in layers V 
and VI (167). Kainate receptor densities are high in layers I, II, V and VI with low densities in 
layer III (167).  
Twenty percent of ACC neurons are interneurons which can be classified in three major 
groups that together make up almost 100% of all interneurons; interneurons expressing 
parvalbumin (PV), somatostatin (STT) and the ionotropic serotonin receptor  (5HT3aR) (236). 
Other calcium binding proteins can be used to identify interneurons as well, such as calretinin 
and calbindin,  but they either colabel with one of the major three groups or comprise only a very 
small percentage of the total population (236). Parvalbumin neurons are either basket cells, 
neurons that synapse at the soma and proximal dendrite of target cell, or chandelier cells, neurons 
that project to axons of pyramidal neurons  (236). These fast spiking interneurons are located in 
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all layers but constitute about 45% of interneurons in layer V and VI and only 25% in layer II and 
III (236). Small populations of somatostatin neurons are present in layer I but they are more 
abundant throughout layer II, III, V and VI. These cells can be identified by their bursting activity 
(236).  5HT3aR neurons primarily populate the superficial layers of the cortex, constituting about 
60% of all interneurons in the layers I, II and III. GABA is the major inhibitory neurotransmitter 
in the ACC. Inhibitory postsynaptic currents are mainly caused by GABAA receptors (237) and 
are thought to modulate pain-induced avoidance behavior (238). GABAA receptors are most 
prevalent in layer III, V and VI, and are highest in the latter (167). GABAergic interneurons have 
different electrical properties in relation to where they are situated in the cortex. For instance, 
interneurons that fire with a burst-like pattern are mostly found in layer V whereas regular 
spiking interneurons have been recorded in layer II, III and V (231). Irregular spiking 
interneurons typically fire an initial burst that is followed by irregularly timed single action 
potentials. This small fraction of interneurons is located in layer II and III. Many connections 
from pyramidal cells onto interneurons are excitatory in layers II until V. However, some 
interneurons receive depressing synapses from pyramidal neurons in layers II and III (231). 
 Apart from glutamate and GABA receptors, the ACC contains other receptors such as 
muscarin, serotonin and dopamine receptors. Muscarin receptor densities are highest in layer II 
and III whereas noradrenaline receptors are present in layer I and III. Serotonin receptors are 
most prevalent in layer I, II, V en VI and dopamine receptor concentrations are highest in layer I 
through III.  
 
E. Role of the ACC in the emotional processing  
Although many clinical studies showed the ACC’s role in emotional processing (69), the exact 
functional contribution is still unclear as the ACC plays a role in both the generation and 
regulation of emotions [69, 70]. For instance, activation of the ACC has been documented in the 
induction of emotions such as envy (239), fear (240), sadness (241, 242), disgust (243) and anger 
(244). Besides, the ACC participates in affective processing indirectly by modulating functional 
connectivity with other brain regions, such as the insula and the amygdala (245). The ACC has 
also been related to the modulation of autonomic responses during meditation  (246), emotional 
coping (247) and in response to rewarding stimuli (248).  
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Interestingly, different subregions of the ACC respond differently to emotional stimuli 
depending on the type of experimental tasks used. Imaging studies have shown hypoactivity in 
dorsal portions of the ACC (162) and hyperactivity in the ventral regions during the processing of 
emotional conflict (249), while the latter is deactivated during the passive viewing of emotional 
pictures (250). Together with other cortical regions (ventro- and dorsomedial prefrontal cortex, 
posterior cingulate cortex, lateral parietal cortex and superior temporal gyrus), the ACC is 
considered to be part of the default-mode network that is characterized by high neuronal resting-
state activity (251). In contrast, some studies have demonstrated that the ACC is deactivated 
when it is a part of the default-mode network (250, 252). For instance, a study by Northoff and 
colleagues, in which functional Magnetic Resonance Imaging (fMRI) was combined with resting-
state magnetic resonance spectroscopy, indeed showed a negative blood oxygen level-dependent 
(BOLD) response which was correlated with increased GABAergic and decreased glutamatergic 
activity within the ACC during the judgment of scenic photographs (252). Another explanation 
for the distinct roles of the ACC subregions in emotional processing might be related to the 
ACC’s influence on other brain structures such as the amygdala. Given the strong reciprocal 
connectivity between the ACC and the amygdala, any assessment of the role of the ACC in the 
processing of emotional information should benefit from the consideration of cinguloamygdala 
interaction. Indeed, emotional conflict is associated with the activation of the rostral ACC 
followed by decreased amygdala activation suggesting that the rostral ACC has top down control 
over amygdala (253).  
 
F. Role of the ACC in fear and fear learning 
The ACC has a role in the various components of fear processing such as the perception of threat 
or of unconditioned stimuli (appraisal), the pairing of unconditioned stimuli and conditioned 
responses (acquisition and conditioning), the execution of fear response, and the regulation of 
these processes (extinction). Most of the time these processes have been investigated with 
classical Pavlovian fear conditioning paradigms, which consist of pairing a neutral conditioned 
stimulus (CS), such as a tone, with an aversive unconditioned stimulus (US), such as a foot 
shock. 
 Human neuroimaging studies pointed out the important role of the dACC throughout the 
ACC for fear processing such as CS appraisal (254), expression of  fear responses (240) and fear 
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learning processes (255) by showing the activation of the dACC during acquisition of fear 
conditioning (256, 257) and during the expression of conditioned fear responses (240). In the 
latter study, both MRI and fMRI showed that the thickness and the activity of the dACC 
positively correlated with fear conditioned skin conductance while participants underwent a 
stimulus-shock association (240). Recent studies using instructed fear paradigms, in which 
subjects are told before the experiment that a given CS might be followed by an US, had shown 
that the dACC is specifically involved in conscious appraisal but not in the expression of the fear 
response (254, 258). In animals, fear can also be acquired through observation of others 
suffering. A preclinical study in which observer mice developed freezing behavior while 
watching demonstrator mice receiving repetitive foot shocks reported that the inactivation of the 
ACC by injecting lidocaine or deleting Cav1.2Ca
+2
 channels blocked observational fear learning 
and reduced pain responses (255).   
It has also been shown that trace fear conditioning, in which the US follows by a stimulus 
free empty interval separating the cessation of the CS from the onset of the US, also engages the 
ACC (259-262). Furthermore, it has been reported that calcium/calmodulin-dependent protein 
kinase IV overexpressing mice showing increased ACC synaptic long-term potentiation have 
increased acquisition of trace fear (260, 263), while mice with ACC synaptic plasticity 
deficiency, due to either FMR1 knockout or chronic pain, have impaired trace fear conditioning 
(261, 262). Although the lesioning of the ACC has no impact on delay fear conditioning, it 
impairs the increased ACC neuronal activity observed in trace fear conditioning (264). Based on 
in vivo single-unit and local field potential recordings, a recent study implicated ACC pyramidal 
and non-pyramidal neurons in reinstating movement after freezing behavior during trace fear 
conditioning (259). Clinical studies have also shown the involvement of the ACC in delay fear 
conditioning (265). 
Learning processes including acquisition, consolidation, storage and retrieval of fear 
memory are important parts of fear processing. There is an abundance of studies showing the 
ACC’s role in generating and retaining fear memory (266, 267). Interestingly, clinical fear 
conditioning studies revealed that activation of the rACC occurs after learning of repeated CS-US 
pairing (265, 268, 269). Not surprisingly the ACC-amygdala interaction plays a role in generating 
fear memory. A study aiming to investigate top-down control of the rACC subregion over 
amygdala during pavlovian fear acquisition showed that exitotoxic lesions, temporal inactivation 
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or activation of the rACC projecting to the basolateral amygdala altered the acquisition of the 
tone-shock associative learning (270). Similarly, injecting methylphenidate into the ACC or the 
amygdala facilitates fear memory consolidation in rats, probably by increasing dopamine and 
norepinephrine in the synaptic clefts (271). Apart from generating fear memory, the ACC is also 
involved in the consolidation and reconsolidation of recent and remote contextual fear memory 
(266). Indeed, rats receiving protein synthesis inhibitor anisomycin immediately after 
consolidation or after re-exposure to the context of the foot shock, showed decreased freezing 
behavior during the retest. Non human primate studies further showed that the dACC is involved 
in retaining aversive memory since low frequency stimulation of the structure prevents 
spontaneous recovery of aversive memory during extinction (272).  
Some mechanistic studies showed that fear processing induces plastic changes within the 
ACC (266, 273). For instance, Descalzi and colleagues demonstrated that memory consolidation 
within a trace fear learning paradigm is mediated by GluN2B dependent trafficking of CP-
AMPARs. Besides that, inhibition of NMDAR-NR2B in the ACC disrupts memory formation 
and memory consolidation (266).   
 
G. Role of the ACC in mood disorders and other psychiatric disorders 
With the advent of neuroimaging techniques, a growing number of studies investigate the brain 
systems involved in mood disorders and develop neurocircuitry models.   Unsurprisingly, the 
physiological role of the ACC in emotional and cognitive processing is reflected in its role in 
such models of mood disorders (Table 2). Indeed, the ACC is known to display functional and 
morphological alterations in major depressive  disorder (274-278), bipolar disorder (279), 
obsessive compulsive disorder (280), anxiety (281, 282), post traumatic stress disorder (283-285) 
and schizophrenia (286-288). In this part, we focus on major depressive disorders, obsessive 
compulsive disorders (OCD), schizophrenia as well as generalized anxiety disorders and post 
traumatic stress disorders (PTSD). We describe various functional/anatomical imaging studies 
and neurochemical findings supporting the role of the ACC in mood disorders, revealing the 
effect of treatment on the ACC function and evaluating the relationship between the ACC and 
other limbic structures in mood disorders.      
A common finding seems to be that the ACC’s size is a predictor for the development of 
mood disorders. Clinical structural analysis of the ACC revealed that a reduction of its volume is 
MDD: Major depression disorder, PTSD: Post-traumatic stress disorder, GAD: General anxiety disorder, PD: Panic disorder,
OCD: Obsessive-compulsive disorder
ACC: Anterior cingulate cortex, sACC: subgenual ACC, vACC: ventral ACC, dACC: dorsal ACC, rACC: rostral ACC
fMRI: Functional magnetic resonance imaging, PET: Positron emission tomography, EEG: Electroencephalogram
SPECT: Single photon emission computed tomography
ERN: Error-related negativity
Mood-disorder Structure Approach Results References
MDD sACC
PTSD
GAD
Borderline
OCD
Schizophrenia
Table 2. Summary of studies on ACC activity changes in mood-disorders. 
fMRI, PET, EEG Activity decrease Pizzagalli et al., 2004
PET Activity increase Drevets et al., 2002
vACC fMRI, PET Activity increase Mayberg et al., 1999, Yoshimuro et al., 2010
dACC fMRI, PET, SPECT Activity decrease Mayberg et al., 1999
rACC fMRI Activity decrease Shin et al., 2001, 2005
rACC fMRI Activity decrease Swartz et al., 2014, Weaton et al., 2014
Fonzo et al., 2016
vACC fMRI Activity increase Scherpiet et al., 2014, Minzenberg et al., 2007
dACC fMRI Activity decrease Gruber et al., 2004, Scherpiet et al., 2014
Soloﬀ et al., 2015
ACC EEG ERN decrease de Bruijn et al., 2006
rACC fMRI Activity increase Fitzgerald et al., 2005, Cavanagh et al., 2010
ACC fMRI Activity increase Mendrek et al., 2005, White et al., 2011
ACC EEG, PET Activity decrease Gallinat et al., 2002, Kim et al., 2003
Boksman et al., 2005, Fu et al., 2005
Wagner et al., 2013, Lee et al., 2014
Yan et al., 2012a
ACC fMRI Activity increase Pillay et al., 2007PD
ACC fMRI Activity increase Winter et al., 2015
dACC fMRI Activity decrease Cavanagh et al., 2010
ACC fMRI Activity increase Hou et al., 2012, Cheng et al., 2013
dACC fMRI Activity decrease Lee et al., 2014
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correlated with the number of depression episodes (274). Additionally, less sACC (275-277) and 
vACC (278) gray matter volume correlated to an increased risk of major depressive disorder. 
Somewhat contrasting with these findings is a study relating a smaller dACC to having a higher 
quality of life-questionnaire score (289). Reduction of the ACC volume is also found in various 
other psychiatric disorders, including post traumatic stress disorder (PTSD) (283-285), borderline 
personality disorder (290, 291), schizophrenia (286-288) and OCD (280). In anxiety disorder an 
increase of dACC grey matter volume has been reported (281). In both the PTSD (285) and 
borderline personality disorder (291, 292), the symptom severity was negatively correlated with 
the size of the ACC. Apart from grey matter volume changes, ACC white matter integrity can 
also be affected in mood disorders. White matter reductions have been reported in depression 
(293, 294), anxiety (295),  PTSD (296) and schizophrenia (297). In depressed patients it has been 
shown that multiple fiber tracks, including that of the ACC, are decreased (294). Therefore, loss 
of ACC white matter alone might not always explain depression prevalence. Nevertheless, white 
matter alterations can lead to functional connectivity changes (293, 298, 299) which is 
hypothesized to underlie mood disorder symptoms. As can be read in the following sections, 
apart from ACC volume many clinical and preclinical studies relate connectivity and activity 
abnormalities of the ACC to mood disorders.  
 
1. Role of ACC in Major Depressive Disorder (MDD) 
Insight from imaging studies 
Volumetric imaging is a commonly used technique when studying depression. A common finding 
is that the ACC’s volume can be used as a predictor for the development of MDD (274-278). 
Hastings et al. found that this volumetric alteration is gender dependent since depressed males 
had two times less sACC volume than depressed females (300). Genetic factors have also been 
implicated in the volume differences. For instance, it has been shown that healthy subjects 
carrying the allele for the short version of the gene for the promoter region of the serotonin 
transporter had smaller sACC and impaired coupling between the sACC and amygdala (301). 
This polymorphism had already been associated with development of depression (302, 303) and 
anxiety (304). This volumetric alteration could be explained by glial cell (305) or oligodentrite 
loss (306). Additionally, synaptic dendrite decrease might be involved (307). Although not many 
animal studies have focused on cell loss in animal depression models, one study showed that the 
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loss of glial cells in prefrontal areas, including the cingulate areas, is enough to induce 
depressive-like behavior (308). On the contrary, some studies didn’t find any volumetric 
differences between depressed and non-depressed patients (309-311). This might be explained by 
a different definition of the subregions of the ACC, heterogeneity of patients, the influence of 
comorbid diseases, stage of the illness (312) or differences in treatment history (313).  
 Functional neuroimaging studies using positron emission tomography (PET), single 
photon emission computed tomography (SPECT), functional magnetic resonance imaging (fMRI) 
or magnetic resonance spectroscopy (MRS) have identified subregion dependent ACC 
abnormalities in depression which were, in some cases, even correlated with the severity of 
depression (314). By measuring glucose metabolism and blood flow during resting state, several 
studies showed hypoactivity in the dACC (315) while the ventral part, such as the perigenual 
ACC, was reported to be hyperactive (315, 316) in depressed patients. These different functional 
responses in distinct subregions of the ACC were correlated with symptom clusters such as 
sadness/depressed mood which were accompanied by an increase of vACC activity and 
decreased activity in the dorsal ACC (315). However, results concerning the sACC activity could 
be contradictory since both increased (317) and decreased activity (311) in depressed patients 
have been reported. The supposed shift between dorsal and ventral activity in resting state fMRI 
may correspond to the frequently observed awareness shift between internal and external mental 
contents in depressed patients (318). Indeed, studies focusing on resting state activity in both 
healthy and MDD subjects point out that internal mental contents are related with the perigenual 
ACC and the default-mode network while external mental contents associated with dorsolateral 
prefrontal cortex and the executive network (318). Several studies showed that these functional 
alterations within the ACC could be reversed by antidepressant treatment (317, 319-321), TMS 
(322), ECT (323), DBS (324), cognitive behavioral therapy (325) and psychotherapy (326). 
Interestingly, some studies have even reported that the activity of the ACC is a predictor for the 
treatment response including antidepressant medications (327-329), sleep deprivation (330) and 
cingulotomy (331).  
 Imaging studies also showed alterations in various neurotransmitter systems previously 
implicated in depression physiopathology such as decreased glutamatergic activity (332-334), 
abnormal GABA level (335-337), decreased serotonin synthesis (338), increased serotonin 
transporter (339), decreased dopamine 2 receptor binding (340) in the ACC of the depressed 
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patients. Northoff and Sibille (2014), hypothesized that the abnormal balance between dACC and 
vACC, thus between internal and external mental contents in awareness, in MDD can be 
associated with the changes in GABA interneurons. Indeed, somatostatin (341) and parvalbumin 
levels (342), neuropeptides expressed in GABA neurons that regulate the excitatory input or 
output of pyramidal cells respectively, are low in  MDD patients which could translate into an 
imbalance between pyramidal cell input and output and lead to abnormal resting state activity 
(318). 
Alterations in network connectivity within the ACC might also contribute to the development of 
mood-disorders. For instance, resting state fMRI studies reported a decrease in local dACC 
network connectivity among individuals susceptible to the depressogenic effects of early life 
stress (343). Treatment resulted in symptom improvement and improved information processing 
(344). Besides cortico-cortical connectivity, Ho and colleagues showed an increase in functional 
connectivity between the sgACC and the amygdala and a decrease in connectivity between 
sgACC and fusiform gyrus, precuneus, insula, middle frontal gyrus in MDD patients in a fear 
facial recognition task (345). The sgACC dysregulation thus might be responsible for the biased 
processing of negative stimuli and results in an imbalance of functional brain networks (345). In 
another study, analyzing structural connectivity in patients, showed a decrease in connectivity 
between the right rACC and the bilateral superior frontal gyrus (346), which was correlated with 
depression severity.  
 
Insight from lesion studies 
Clinical studies showed that anterior cingulotomy, a lesion of the cingulum bundles, can be 
clinically used as a last resort treatment for patients suffering from treatment resistant MDD. This 
type of ablative surgery leads to symptom improvements in around 75% of the patients with 
intractable major depression (347). Anterior cingulotomy is more successful when the lesion is 
performed more anteriorly and interrupts the connectivity with the posterior part of the ACC 
(348). Preclinical studies also showed that the lesion of the ACC modulates mood related 
parameters (349, 350) as well as blocks the chronic pain-induced anxiodepressive-like behaviors 
(9). 
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Neuroimmune and neuroendocrine hypothesis 
A growing number of studies suggest that inflammatory processes, characterized by increases in 
proinflammatory cytokine activity, have a significant impact on emotional regulation and mood 
disorders (351-353). A study with 31 healthy participants showed an association between 
increased soluble TNF-alpha, markers of inflammation, in oral fluids which was correlated with 
the hyperactivity of the dACC (351) support the idea that neuroinflammation in MDD could be 
associated with structural and functional anomalies in various brain regions (352). Another study 
indicates that inflammation-associated mood deterioration correlates with increased activity 
within the sACC during performance in an emotional face processing task. In the same study, 
inflammation-associated mood change was associated with reduced connectivity of sACC to 
amygdala, medial prefrontal cortex, nucleus accumbens, and superior temporal sulcus, which was 
correlated with peripheral IL-6 levels (353). 
 Besides, suicidal MDD patients had increased expression levels of stress-related candidate 
genes such as corticotrophin releasing hormone and neuronal NOS-interacting DHHC domain-
containing protein with dendritic mRNA (NIDD), which plays a role in NO signaling (354), in 
their ACC while major depressed non suicide patients only presented decreased NIDD and 
increased 5-hydroxytryptamine receptor 1A (5-HT1A) expression levels (355) suggesting that 
depressed patients who committed suicide have different gene expression patterns within the 
ACC than depressed patients who died of causes other than suicide. 
 
Other animal studies 
Several clinical studies suggest that an increased ACC activity may underlie the depression 
phenotype. This notion is further supported by animal studies. For instance, in the social-defeat-
paradigm, the presence of depressive-like behavior is accompanied by an increased cingulate 
activity as shown by c-Fos staining (356). Reciprocally, pharmacological inactivation of the rat’s 
infralimbic cortex, which can be argued to be equivalent to the primate subgenual ACC, leads to 
a decrease of the depression-like phenotype (357). However, the detailed influence of cingulate 
sub-regions requires further exploration, since lesions of the rACC in the rat has been reported to 
have either no effect on the immobility in the forced swim test (349), or to result in increased 
immobility (350). 
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2. Role of the ACC in Anxiety 
Anxiety disorders as well as trauma and stress related disorders such as PTSD (DSMV) are also 
related with the alterations of the activity and connectivity of the ACC.  
Insights from imaging studiesIn PTSD, rACC activity is diminished and amygdala activity is 
increased in response to trauma related words, suggesting that the r/v ACC has a regulating role 
by inhibiting the amygdala in response to fearful stimuli (358, 359). This ACC activity decrease 
was found to negatively correlate with avoidance behavior, as measured by the Clinician 
Administered Posttraumatic Stress Disorder Scale (360). A similar hypothesis has also been 
proposed for general anxiety disorder (361) as hypoactivation of the prefrontal cortex and the 
rACC have been reported   (362-364) which results in exaggerated limbic activity due to 
hyperactivation of the amygdala (362, 363). This exaggerated limbic activity makes it difficult 
for these patients to divert attention away from threat. The relation between ACC and limbic 
activity is further supported by a case study in which a patient experienced an instant panic attack 
during brain surgery when the dACC was damaged accidentally during tumor removal (365). 
However, some studies relate an increase of ACC activity to disrupted emotional 
processing in panic disorder patients. One study shows an increase in ACC activity in response to 
the presentation of happy faces (366). This increase could be due to the increased conflict 
monitoring as a result of greater attentional demands or a consequence of compensatory 
mechanisms. This is further supported by a clinical study showing that healthy subjects with high 
trait-anxiety do show an increase of glutamine and glutamate in the ACC which indeed suggests 
an increase in activity (367). Additionally, cholecystokinin-tetrapeptide induces anxiety in 
humans accompanied by an increase of rACC activity (368).  
These activity changes could be caused by the connectivity alterations. For instance, early 
life stress has been shown to induce anxiety in adult life which coincides with decrease in 
connectivity between the ACC and the amygdala (369). Half of children with an inhibited 
temperament develop social anxiety disorder, those that do are shown to have more negative 
connectivity between the rACC and the bilateral amygdala (370) whereas weaker coupling 
between the ACC and the amygdala has also been reported (295, 371). Patients with fewer 
symptoms showed greater ACC activity and better functional connectivity between the ACC and 
the amygdala (370). 
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Treatment 
Interestingly, different treatment strategies improve symptoms by counteracting ACC activity. 
The administration of anxiolytic drugs, such as benzodiazepines has been found to influence the 
ACC activity (372),  decrease ACC metabolism (373) and reduce anxiety in the anticipation of 
pain by reducing ACC activity (374). Apart from these benzodiazepines, tiagabine, a GABA 
reuptake inhibitor which is usually administered together with benzodiazepines, has been shown 
to increase ACC glucose levels as well as improve generalized anxiety disorder symptoms (375).   
Non-pharmacological treatments can also treat anxiety and alter ACC activity. Cognitive 
behavior therapy (CBT), for instance, has been shown to increase dACC activity in generalized 
social anxiety disorder patients (376, 377) and decrease limbic activity in generalized anxiety 
disorder (378) thereby improve  symptoms. CBT treatment responders in panic disorder patients 
with agoraphobia were primarily carriers of the long version of the serotonin transporter gene for 
5-HTTLPR, showing that serotonin signaling might be implicated (379). Treatment with 
antidepressants acting on the serotonergic system, however, had no effect on the exaggerated 
error-related negativity, a signal attributed to ACC activity, in obsessive compulsive disorder-
related anxiety patients (380). Interestingly, oxytocin administration has been shown to improve 
functional connectivity between the ACC and amygdala in generalized social anxiety disorder 
patients which shows that oxytocin has a role in enhancing the integration and modulation of 
social responses (381, 382) 
 
Insights from preclinical studies 
A number of animal studies suggest that anxiety-like behavior coincides with ACC hyperactivity. 
For instance, rats submitted to chronic unpredictable mild stress showed an increase in ACC fos 
immunohistochemistry and more avoidance behavior (383). Additionally, anxiety can be induced 
by traumatic events that coincide with firing rate changes in ACC neurons, in which the majority 
of these neurons show a  transient hyperactivity (384). Acute intraperitoneal injection of 
midazolam, a benzodiazepine, reduces anxious behavior in the elevated plus maze (385). 
Supporting this notion; inhibition or ablation of the ACC is found to have anxiolytic effects 
(386). For instance, when the ACC is lesioned animals no longer show an anxiety-like phenotype 
in a mouse model of neuropathic pain (9). Additionally, administration of GABA receptor 
agonists into the ACC has been shown to reduce anxiety-like behavior in mice (386). Similarly, 
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low-frequency stimulation, a stimulation protocol known to induce long-term depression, of the 
dACC prevents recovery of aversive memories after traumatic events under a tone air-puff 
paradigm (272).  
A range of molecular mechanisms seem to be involved in anxiety. For instance, pain-
related anxiety seems to be mediated by expression of extracellular signal regulated-kinase 
(ERK) in the ACC (387, 388) and inhibiting ERK activation in the ACC after hind paw incision 
attenuated pain-related anxiety-like behavior (389). In addition, oral treatment with MAPK 
inhibitor reduced anxiety-like behavior in rats and decreased microglia count and specific NMDA 
receptors in the ACC after spinal cord injury which might indicate the involvement of LTP (390). 
This is further supported by a study showing anxiolytic and analgesic effects of LTP blockage in 
the ACC (391). Postsynaptic LTP requires NMDA in the ACC whereas presynaptic LTP requires 
kainate receptors (391). Blocking the presynaptic LTP mechanism has anxiolytic and analgesic 
effects (391). Apart from the glutamatergic system, anxiety might also be mediated by the 
serotoninergic system. In a mouse model of neuropathic pain by nerve ligation, injection of 
SSRIs into the ACC reduced anxiety-like behavior (392). Lower serotonin levels in the amygdala 
were associated with smaller ACC volumes in high trait anxiety marmosets (393). This is similar 
to the findings from an earlier study in which animals from an unpredictable chronic mild stress 
model showed an increase in serotonin metabolism in the ACC and a decrease of kynurenic acid, 
a byproduct of serotonin metabolism, in the amygdala (394).  
 
3. Role of the ACC in borderline personality disorders 
Borderline disorder personality (BPD) is a serious mental illness marked by unstable moods, 
behavior and relationships. Patients have problems with regulating emotions and thoughts, show 
impulsive and reckless behavior and frequently endure unstable relationships with other people 
(NIMH).  
 
Insights from clinical studies 
In BPD both cognitive and emotional processing are altered. Volumetric studies have shown that 
both ACC and amygdala grey matter volume is decreased in BPD patients (395, 396). 
Furthermore, the dACC shows decreased activity during the anticipation and the perception of 
non-emotional stimuli in BPD patients as compared to healthy controls (397, 398).  This is 
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further reflected by the finding that error-related negativity amplitudes, a signal generated by the 
ACC after erroneous responses, were decreased in BPD (399). This reduced action monitoring 
might be the reason why BPD patients do not learn from their errors in comparison to healthy 
individuals, which might be caused by a reduction of functional connectivity between the ACC 
and other regions involved in cognitive processes. For instance, in a task in which participants 
had to attribute mental states to someone else, it was found that functional connectivity between 
the ACC and regions such as the left superior temporal lobe, the inferior parietal lobes and the 
right mid-cingulate cortex were decreased (400). 
 An abundance of studies indicate that BPD patients suffer from increased emotionality. For 
instance, in the anticipation of negative stimuli BPD patients show an increase of pregenual 
activity (398) whereas increased ventral activity during anger processing has also been reported 
(401). dACC activity seem to altered as well; in a study showing dACC involvement in BPD, 
emotional experiences of exclusion were studied using a virtual ball tossing game in which the 
participant was eventually excluded from participating (402). BPD patients felt more excluded 
than healthy controls during the non exclusion condition which was correlated with increased 
dACC activity (402). A number of studies show that the functional connectivity between the 
amygdala and the vCC is increased while processing emotional information (403), this then leads 
to amygdala hyperactivity (404) which disrupts cognitive functioning.  
Emotional processes also interfere with cognitive processes such as attention, working 
memory and episodic memory. For instance, BPD patients previously exposed to emotional 
imagery before partaking in a cognitive stroop task perform worse than when they are not 
previously exposed to such imagery. In both conditions, however, they show an increase of ACC 
activity (405). Working memory is affected as well in these patients. In a recent study it was 
shown that emotional distractions lead to a stronger positive connectivity between the dACC and 
areas involved in attention and salience detection such as the left posterior cingulate, insula, and 
frontoparietal regions in BPD patients (406). Additionally, episodic memory can be affected by 
emotional distractions. Another study showed that during an episodic memory task using 
emotional pictures, the amygdala became hyperactive and the ACC hypoactive in BPD patients 
(407). These findings indicate that borderline patients pay more attention to emotional and social 
information while performing cognitive tasks than healthy control. 
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Treatment 
Borderline personality disorder is usually treated by talk therapy such as CBT. Due to the 
complexity of this mental illness, medications generally target specific symptoms such as 
depression, impulsivity and anxiety (408). To our knowledge no studies have been done on 
effects of pharmacological treatment on cingulate functionality. CBT however, has been found to 
decrease ACC activity during the viewing of emotional stimuli (409). This reduction of ACC 
activity might underlie symptom improvement.  
 
4. Role of the ACC in obsessive compulsive disorder 
Insights from clinical studies 
Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears 
(obsessions) that lead patients to do repetitive behaviors (compulsions). Several studies suggest 
ACC dysfunction in patients with OCD. For instance, imaging studies demonstrate increase 
resting state activity (410, 411) and increase ACC grey matter volume (412). Hyperactivity of the 
ACC in patients with OCD has been shown to increase with symptom provocation and to 
normalize with treatment. Electrophysiological evidence linked this region to error-related 
processing as it generates activity during the detection of errors, which is shown to be affected in 
OCD patients (413). For instance, the severity of OCD symptoms has been correlated with an 
increased rACC error-related processing (413).  
Functional connectivity studies further showed that connectivity between the ACC and the 
orbital frontal cortex (OFC) is decreased in OCD patients (410, 414). As OFC neurons evaluate 
current choices and the ACC encodes the prediction of the choices and evaluates prediction 
errors, this might be part of the neuronal basis for the impaired error detection phenotype in OCD 
patients (410, 414). Additionally, decreased connectivity between these regions after sad mood 
might reflect why patients experience more OCD symptoms during negative emotional states 
(415).  
Moreover, it has been shown that the rACC is more active in OCD patients during response 
competition tasks while the dACC is deactivated during reinforced learning tasks (416). The 
increase of rACC activity was related with the difficulties in conflict processing and dACC 
deactivation during reinforced learning tasks could underlie the patient’s inability to learn from 
their futile repetitive behavior (416). 
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Treatment 
Accordingly, a chronic anterior capsular electrostimulation decreased both the subgenual 
ACCactivity and the OCD rating scores (417). High ACC metabolic rate has been found to 
predict clinical response to risperidone, a serotonin and dopamine antagonist (418). On the other 
hand, responders to antidepressant drug treatment exhibit significantly lower rACC activity after 
treatment (419) while the CBT responders displayincrease dACC activity. (420). 
 
5. Role of the ACC in schizophrenia 
Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and 
behaves (NIH). The Symptoms of schizophrenia falls into three categories: positive, negative and 
cognitive symptoms. Positive symptoms are psychotic behavior that under normal circumstances 
are not experienced by healthy individuals such as; delusions, disordered thought and 
hallucinations (DSMV). Negative symptoms are commonly expressed as lack of emotion, 
poverty of speech and the inability to experience pleasure or the lack of motivation (DSMV). 
Finally, cognitive symptoms include memory and attention deficits (DSMV).  
Most studies relate alterations in ACC connectivity to negative and cognitive symptoms in 
schizophrenia. Concerning ACC activity in schizophrenia, both increased (421, 422) and 
decreased activity (423-427) have been reported. Nevertheless, the predominant part of these 
studies report decreased activity during cognitive tasks (423-427).  
 
Insights from clinical studies 
In a study investigating emotional salience in schizophrenia, patients were asked to rate their 
emotional response to emotionally laden pictures. When both positive and negative scenes were 
presented at the same time, decreased dACC activity was observed which might explain deficits 
in the processing of emotional information (428). Indeed, decreased ACC activity might be the 
cause of negative and cognitive symptoms in schizophreniasince an abundance of evidence report 
cortical thinning and ACC activity decrease in the presence of negative symptoms in 
schizophrenia (429). Additionally, ACC activity decrease has been correlated with cognitive task 
performance, providing a neuronal basis for the cognitive deficit in schizophrenia patients (430).  
For instance, functional connectivity decrease between the ACC and the mediodorsal thalamus 
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has been reported and may disrupt cognitive processing (423). Interestingly, an increase in 
dorsolateral prefrontal cortex and the mediodorsal thalamus connectivity might function as a 
compensatory mechanism (423). Aside from interregional connectivity changes, hemispheric 
asymmetries are also reported in schizophrenia (430). Study by Yan et al. showed decreased 
positive connectivity with the bilateral putamen together with increased negative connectivity 
with the posterior cingulate cortex (430).  
Functional connectivity decrease has been related to aggression in schizophrenia also. In a 
study using the Urgency Premeditation, Perseverance and Sensation-Seeking scale, cortical 
thickness in areas including the rACC was found to correlate with urgency scores (431) in which 
the subconstruct of ‘urgency’ is thought to play an important role in aggression in schizophrenia 
patients. In addition, resting-state fMRI showed that reduced functional connectivity of the rACC 
correlated with urgency scores (431). These findings are supported by another study showing that 
violent men with antisocial personality disorder or schizophrenia show a significant ACC volume 
decrease (432).  
Some molecular mechanisms have been proposed for understanding the schizophrenia 
physiopathology concerning the ACC. Molecular findings indicate that α-Amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) and N-Methyl-D-aspartate (NMDA) signaling might 
be responsible for the disrupted ACC activity in schizophrenia. For instance, transmembrane 
ionotropic glutamate receptor regulatory protein (TARP) dysregulation is hypothesized to result 
in decreased AMPA receptor activity (433).  Neurogranin, which is associated with NMDA 
receptor signaling (434), and N-acetyl aspartate (NAA) concentration, whose release is increased 
due to NMDA receptor activation, are both reduced in schizophrenia patients (435). This 
disturbed glutamate signaling might be the cause for the decreased ACC activity observed in 
schizophrenia patients.  
 
Treatment 
Acute tryptophan and tyrosine/phenylalanine depletion was found to significantly improve 
attention in schizophrenia patients, which could indicate that reduced dopamine and serotonin 
activity in the striatum, ACC and PFC may play a role in attention (436). This is further 
supported by a study showing that flupentixol and quetiapine, serotonin and dopamine 
antagonists, improve prefrontal function especially in patients with weak initial ACC function 
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(437). Modafinil, a serotonin antagonist, increased ACC activity during working memory tasks 
which was correlated with cognitive performance in schizophrenia patients (438). Additionally, 
cognitive therapy improves activity in attention and working memory networks including 
dorsolateral prefrontal cortex, ACC and frontopolar cortex (439). Functional connectivity 
between the striatum and ACC can be improved by risperidone or aripiprazole, serotonin and 
dopamine antagonist, treatment (440) and reduced ACC blood flow in schizophrenia patients 
(441) can be restored by clozapine treatment in schizophrenia patients (442).  
 
H. The role of the ACC in pain 
Physical pain represents a necessary alarm signal for body integrity and survival. According to 
the literature, it is composed by at least two distinct dimensions: the sensory-discriminative 
component, encompassing qualities such as the localization and intensity of pain, and the 
affective-motivational component, characterized by the unpleasantness or negative aspect of pain. 
Imaging studies highlighted the implication of many brain regions during physiological and 
pathological pain processing, including the ACC (443). Indeed, a growing number of clinical and 
preclinical studies explored its critical role in sensory-discriminative and affective-motivational, 
as well as in the cognitive and attentional aspects of pain.  
 
1. Insights from clinical studies 
With the first cingulotomy by Ballantine et al. (1967) in the 60’s, the ACC became an important 
target for patients’ suffering from intractable pain resistant to classical treatments (444). 
Manipulating this structure allows a decrease in the perception of the unpleasantness of pain 
without inducing any change in the sensoridiscriminative aspect of the noxious stimulus (444). 
These days, ablation of the ACC remains a possible treatment for pain relief (445), even when 
less invasive procedures targeting the ACC such as deep brain stimulation (446) or repetitive 
transcranial magnetic stimulation (447) are favored.  
 
The role of the ACC in physiological conditions 
The ACC can be activated by different type  of noxious stimulation. For instance, it has been 
demonstrated in healthy subjects that mechanical (448-452), electrical (453, 454), thermal (455-
462), incisional (463) and visceral (464-469) noxious stimuli activates different subregions of the 
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ACC. Indeed, some report activation of the contralateral (470) or the bilateral ACC (471), others 
of the midcingulate and of the perigenual part of the ACC (472) or both of the anterior, ventral 
and posterior part of the ACC (462). In fact, the subregional patterns of activation partly change 
according to the type of stimulus. Indeed, the ventral pACC is abundantly activated following an 
electrical stimulus, while a more dorsal part of the pACC is activated after thermal stimulation. 
Besides skin stimulation, several studies have been performed with direct nerve (473) and 
gastrointestinal tract (474) stimulation. Concerning nerve stimulation, only painful stimulations 
induce ACC activation (473, 475).  
 
The role of the ACC in the affective component of pain 
Pain is a multidimensional experience involving both somatosensory and emotional components. 
As a part of the limbic system, the ACC has been associated with the affective/emotional 
component of pain. In the late 90’s, a study using hypnosis and live imaging in humans 
confirmed this role of the ACC (476). Without changing the perceived intensity (i.e. the 
somatosensory component) of a nociceptive stimulus, hypnotic suggestions to healthy subjects 
were made in order to vary the unpleasantness (i.e. the affective motivational component) of the 
stimulation. It appears that the variation of unpleasantness was correlated with the variation of 
regional cerebral blood flow (rCBF) in the ACC, but not in other structures (476). Using a PET 
correlation analysis, another study confirmed the role of the pACC in the encoding of pain 
unpleasantness induced by a hot painful stimulus (477). Interestingly, the pACC was the only 
region where the activation was correlated with an increase of the reported pain unpleasantness. 
Pain relief can be considered as rewarding (478), and another argument for the involvement 
of the ACC in the affective/motivational aspects of pain is the activation of the ACC both in 
human and in rats in response to the offset of an noxious heat stimulus (479). 
 
The role of the ACC in the cognitive component of pain 
Cognition is a major aspect of the pain experience. For example, pain involves different cognitive 
features such as expectation, anticipation, attention, appraisal, empathy, learning and memory 
(480) which are necessary for the defensive behavior in response to actual or potential pain (481). 
Intense pain demands personal attention and, as a consequence, diminishes the cognitive 
functions to process other internal and external information. When pain becomes chronic, the 
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focus towards the pain becomes more prominent (482) and can impair cognitive functions, work 
and social interactions of chronic pain patients. The involvement of the ACC in different 
cognitive parameters is detailed in the following sections. 
 
Expectation – Anticipation of pain  
Pain expectation and anticipation are related but different phenomena. In theory, pain expectation 
is linked to an uncertain painful event whereas pain anticipation is associated with a later, but 
certain painful event. In other words, does the brain react in the same way when the painful event 
is uncertain (expectation) or certain (anticipation) beforehand to the stimulus? Trying to 
anticipate an unpredictable and unfamiliar painful stimulus has been shown to activate the right 
ACC while anticipating a learned painful stimulus decreased the activity in this same region 
(483), showing that expectation and anticipation do not necessarily recruit the same pathway. 
Then, do these cognitive processes modify brain activity related to painful stimuli? A study, in 
which subjects were submitted to either a simple non painful stimulus or non painful stimulus 
alternated with a painful stimulus reported that the activity of the ACC increased in the latter 
condition after the non painful stimulus (484). Another interesting question is whether the 
intensity of pain and the activation of pain-related regions can be influenced by the degree of 
expected pain. When expected pain is manipulated, expectations of decreased pain reduce both 
the subjective experience of pain and the activation of regions involved in pain processing such 
as the ACC and the insular cortex (485).  
 
Attention – Distraction induced by a pain state 
It has been stated that pain modifies attention (481). In the case of acute pain, this directs 
attention to the source of pain, aimed to stop or avoid it. Chronic pain patients can develop 
hypervigilance towards pain (486), which may change social interaction, the ability to work and 
the overall quality of life (487). To evaluate the interaction between pain and attention, studies 
monitoring brain activity during attention demanding tasks and painful stimuli have been 
developed (488). It has been shown that during high demanding attentional tasks, pain ratings 
following thermal noxious stimuli diminish, which was correlated with an increase in rACC 
activity and a decrease in the activity of the cognitive mACC (medial) (488). The decrease in 
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ACC activity is confirmed in another study using CO2 laser pulses as noxious stimuli and MEG 
as a brain activity monitoring technique (489).  
 
2. Insights from preclinical studies 
In this section, we review preclinical studies and discuss them from macroscale (imaging and 
behavioral studies) to microscale level (electrophysiology and molecular studies). 
 
The role of the ACC in the pain processing 
Insights from lesioning studies 
Although some studies showed that lesions of the ACC decreased the sensory component of 
thermal (490) or inflammatory pain (491), others reported no effects of lesions on inflammatory 
response such as licking and biting of the inflamed paw (492) and on mechanical allodynia (493). 
A recent study further showed that the excitotoxic lesion of the ACC did not affect mechanical 
allodynia observed in neuropathic pain induced by peripheral nerve injury. In the same study, 
authors however showed that the lesion of the posterior insular cortex blocks the maintenance but 
not the development of mechanical allodynia (493). These discrepancies may be explained by the 
nature of the painful stimulus that was used (cold vs nerve injury), by the precise localization 
(rostral vs medial, dorsal vs ventral) of the lesion or by the extent (unilateral, bilateral, rostro-
caudal) of the lesion. 
 
Insights from ex vivo electrophysiology 
In the context of a neuropathic pain model, it has been shown that the spontaneous membrane-
potential oscillations and action potential firing of pyramidal neurons of the layers II/III of the 
ACC are higher in neuropathic rats (494). In another study, the nerve injury enhanced the 
probability of presynaptic glutamate release and postsynaptic glutamate AMPA receptor-
mediated responses (49). In chronic inflammatory pain, by using in vitro patch-clamp recordings, 
the group of Zhuo reported an enhancement in neurotransmitter release probability in the ACC 
synapses mediated, at least in part, by calmodulin-stimulated adenylyl cyclase AC1, AC8 (261) 
and TNF-alpha (495). Using a bee venom persistent pain model, Gong et al. observed an increase 
in the frequency and the amplitude of spontaneous excitatory post-synaptic currents (sEPSCs) 
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and a decrease in the spontaneous inhibitory post-synaptic currents (sIPSCs) in ACC slices 
compared to the controls (496).  
 
Insights from in vivo electrophysiology 
Several teams have highlighted an increase of ACC activity in the context of pain processing. 
Electrical stimulation of supraspinal pain centers such as the medial thalamus induces the 
activation of the ipsilateral cingulate cortex (497) confirming the ACC as a target of the medial 
thalamic pain pathway. In anesthetized rats, spontaneous activity of the pyramidal neurons of 
layers II/III is characterized according to their firing pattern: regular spiking, intermediate and 
intrinsic bursting. Acute noxious but not non noxious mechanical stimulation of the hindpaw 
evoked spike responses in all three types of neurons (498). In freely moving rats, noxious laser 
stimulation to the hindpaw induced neuronal activation in the ACC (499). Altogether, these 
studies show that the ACC neurons could be activated by different kinds of peripheral 
nociceptive stimuli (mechanical, thermal) in both anesthetized and freely moving animals.  
 
Insights from imaging studies 
Imaging studies in animals have shown an activation of the ACC during noxious stimulation in 
anesthetized (500) or awake animals (501), whereas innocuous stimulation failed to activate the 
ACC (502). For instance, electrical or chemical stimulation of the forepaw induced bilateral 
activation of the ACC which was decreased by pre-treatment with morphine (503). While most of 
the imaging studies have measured ACC activity following peripheral stimulation in naïve 
animals (500), there are some studies that focus on chronic pain conditions such as neuropathic 
pain. Using autoradiographic techniques to monitor changes in rCBF in a model of chronic 
constriction injury (83), an activation of the ACC can be observed 10 days (504), 2 weeks (505), 
8 weeks or 12 weeks (506) after the induction of neuropathy. Structural MRI studies showed a 
decrease of ACC volume (507) in the spared nerve injury model (88) and functional MRI studies 
confirmed the activation of the ACC 3 weeks after the induction of the neuropathy (508).  
 
Insights from molecular studies 
Molecular manipulations of the ACC modify the expression of several pain behaviors. For 
instance, inhibiting protein kinase M zeta (PKMζ), an atypical isoform of protein kinase C 
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thought to be involved in long term potentiation (LTP), resulted in a reduction of mechanical 
allodynia in neuropathic animals (509). AC1 and AC8, two major adenylate cyclases in the brain 
which link NMDA receptor activation to the cAMP intracellular signaling pathway are 
overexpressed in the ACC (510). Furthermore, it has been shown in the same study that double 
AC1 and AC8 KO mice responses to acute noxious stimulation in the hot plate, in tail flick and in 
the paw mechanical pressure test are similar to those observed in wild type mice. However, 
following paw injection of formalin, nociceptive behavior (licking and biting the formalin 
injected paw), and mechanical allodynia were reduced in double KO AC1/AC8 mice. Mechanical 
allodynia secondary to partial nerve ligation (a neuropathic pain model) was also reduced in the 
same animals (510). Moreover, overexpression of the NMDA receptor subunit NR2B in the ACC 
of mice enhanced nociceptive behavioral response (licking and biting the formalin injected paw) 
and mechanical allodynia to paw injection of formalin although response to acute nociceptive 
stimulation (hot plate and cold plate tests, tail flick test) was unaltered (511). Moreover, local 
injection of NR2B antagonist within the ACC  in the model of formalin-induced inflammation 
reduced nociceptive responses (licking and biting the formalin injected paw) (512). 
 
The role of the ACC in the aversive-motivational component of pain 
Pain has emotional dimensions which, for a long time, were not evaluated in animal research due 
to difficulties to assess and quantify the emotional state of animals. Since the 2000’s, several 
paradigms have addressed this question.  
Some articles reported a role for the ACC in the aversive aspects of evoked mechanical 
allodynia in neuropathic pain models by using the place escape/avoidance paradigm (493). This 
test measures the escape behavior of animals towards evoked pain. Interestingly, this avoidance 
behavior was abolished after bilateral lesion of the ACC while the paw withdrawal response, 
reflecting mechanical sensitivity, remained unchanged. Therefore, the ACC seems to mediate the 
aversive component of evoked pain without affecting its somatosensory aspect in a model of 
neuropathic pain. 
A study published in 2001 associated formalin injection into the hind-paw, which induces 
inflammatory pain, with a place-conditioning paradigm. In this test, the rats developed aversion 
towards the formalin paired context. Interestingly, ACC lesions prior to this place-conditioning 
test prevented the avoidance for the formalin-paired compartment without having any effects on 
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nociceptive behaviors such as paw lifting, licking and flinching (492). These results suggest that 
the ACC mediates the aversive-motivational component but not the sensory component of 
inflammatory ongoing pain.  
Conditioned place preference experiments have been developed recently to study the 
spontaneous pain in a rat model of neuropathic pain (513). The conditioning stimulus is the 
relieving effects of a non-rewarding analgesic drug such as clonidine. The animal shows a 
preference for the analgesic drug-paired context, in absence of any evoked painful stimuli, 
showing that the drug relieves the spontaneous pain state. The lesion of the ACC blocked the 
preference for the analgesic-paired compartment, indicating that the ACC is involved in the 
aversive component of spontaneous pain (514). These results were generalized in other models of 
pain. Indeed, the ACC is also implicated in the affective component of visceral pain (515) and of 
cephalic pain (516). 
 
Discrepancies between studies 
We already showed some discrepancies between the effects of ACC lesions on the response in 
inflammatory and neuropathic pain conditions, with most studies showing no effects of the ACC 
lesions (492, 493, 513) on behavior. However, the molecular studies show involvement of the 
ACC in response to nociceptive stimuli in chronic inflammatory and neuropathic but not in 
response to acute nociceptive stimulation. The observed differential involvement of the ACC in 
pain responses depend probably on the type of pain model used (acute model of pain or tonic 
inflammatory model or chronic neuropathic model) and the precise localization of the 
manipulations in the ACC.  
 
 
 
 
 
 
 
 
VI. Thesis objectives 
This thesis’ main objective was to study the role of the ACC in the comorbidity of neuropathic 
pain and mood-disorders. Our team previously showed the development of anxiety and 
depressive-like behavior after the induction of neuropathy in mice. Here, we  sought to 
understand the neurobiological basis underlying this co-occurrence. 
This work was organized around two objectives: 
 Determine the role of the anterior cingulate in the sensory and affective components of pain as 
well as in emotional consequences. 
We hypothesize that the anterior cingulate cortex is involved in the affective component 
as well as the anxiodepressive consequences of neuropathic pain. By using a lesional approach, 
we compared the role of the ACC with the posterior insular cortex, a cortical region implicated in 
pain processing, in mechanical hypersensitivity, aversiveness of spontaneous pain and 
anxiodepressive consequences of neuropathic pain. This work was completed by activation of the 
ACC in naive animals through optogenetic stimulation to further characterize the role of the ACC 
in mood. 
 Determine the physiological alterations of the ACC over time in the neuropathic pain condition  
Based on both clinical and preclinical literature, we hypothesize that chronic pain and 
mood disorder comorbidity are accompanied by ACC hyperactivity. For this, we performed 
various behavioral tests to evaluate the presence of various aspects of neuropathic pain, and 
anxiodepressive-like behavior within a 6 month time-course. In addition, we studied the 
electrophysiological alterations of the ACC accompanied by these various symptoms in vivo, and 
correlated them to different stages of the pathology. In order to explore a causal link between 
ACC hyperactivity and the affective aspects of neuropathic pain, we completed this work by 
studying the impact of the optogenetic inhibition of the ACC in neuropathic animals.  The next 
two chapters detail the results for each of these two goals. 
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Results 
I. The Anterior Cingulate Cortex is a Criticical Hub for Pain-induced 
Depression 
 
Florent Barthas, Jim Sellmeijer, Sylvain Hugel, Michel Barrot, Ipek Yalcin 
  
In this paper, I participated in designing and performing the optogenetic experiments which was, 
until then, novel at the laboratory.  I also contributed to ex vivo electrophysiological and 
immunohistochemical validation of the technique.  
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chiatryArchival Report BiolPsyThe Anterior Cingulate Cortex Is a Critical Hub
for Pain-Induced Depression
Florent Barthas, Jim Sellmeijer, Sylvain Hugel, Elisabeth Waltisperger, Michel Barrot,
and Ipek YalcinABSTRACT
BACKGROUND: Besides chronic stress, chronic pain is a prevalent determinant for depression. Changes induced in
speciﬁc brain regions by sustained pain may alter the processing of affective information, thus resulting in
anxiodepressive disorders. Here, we compared the role of the anterior cingulate cortex (ACC) and the posterior
insular cortex in the anxiodepressive, sensory, and affective aspects of chronic pain.
METHODS: Neuropathic pain was induced by cufﬁng the right sciatic nerve of C57BL/6J mice. Lesions were
performed by local injection of ibotenic acid and chronic activation of the ACC by optogenetic stimulation.
Anxiodepressive-related behaviors were evaluated through the novelty suppressed feeding, marble burying, splash,
and forced swimming tests. Mechanical thresholds were determined using von Frey ﬁlaments, and the relief of
spontaneous pain was determined by using place conditioning.
RESULTS: The ACC lesion prevented the anxiodepressive consequences of chronic pain without affecting the
sensory mechanical allodynia. Conversely, the tonic or spontaneous pain and the anxiodepressive consequences of
pain remained present after posterior insular cortex lesion, even though the mechanical allodynia was suppressed.
Furthermore, optogenetic stimulation of the ACC was sufﬁcient to induce anxiety and depressive-like behaviors in
naïve animals.
CONCLUSIONS: Our results show that, at cortical level, the sensory component of chronic pain remains functionally
segregated from its affective and anxiodepressive components. Spontaneous tonic pain and evoked allodynia can
be experimentally dissociated. Furthermore, the ACC appears as a critical hub for mood disorders, including for the
anxiodepressive consequences of chronic pain, and thus constitutes an important target for divulging the underlying
mechanism.
Keywords: Anterior cingulate cortex, Anxiety, Behavior, Depression, Insular cortex, Neuropathic pain, Optogenetics23
Biohttp://dx.doi.org/10.1016/j.biopsych.2014.08.004Depression, the most common mental disorder, is a disabling
and long-lasting medical condition, estimated to be the fore-
most contributor to the worldwide burden of disease by 2030
(1). Among several precipitating factors, chronic pain is a
prevalent determinant for depression. Indeed, a mean preva-
lence rate of around 50% for major depressive disorder is
reported in patients with chronic pain (2). The existence of
pain-induced affective disorders is further supported by
preclinical studies showing that chronic pain models can
induce anxiety-like and/or depression-like behaviors in ani-
mals in a time-dependent manner (3–5). While it could be
suggested that chronic pain may be a chronic inescapable
stress (6), preclinical and clinical studies have shown that
sustained neuropathic pain strongly differs from a simple
stress regarding neuroendocrine hypothalamic-pituitary-
adrenal (HPA) alterations, even if it induces similar behavioral
consequences. Indeed, neuropathic pain does not modify the
basal or stress-induced levels of corticosterone or the HPA
axis negative feedback (4,7), while this is the case in the
several models of stress-induced depression (8,9). Another6 & 2015 Society of Biological Psychiatry
logical Psychiatry February 1, 2015; 77:236–245 www.sobp.org/journa
SEE COMMENTARYhypothesis for pain-induced depression could be based on a
shared neuroanatomical substrate, proposing that speciﬁc
brain regions processing pain are also involved in mood-
related processing and that the alterations induced in these
regions by chronic pain may alter the processing of affective
information, thus resulting in mental disorders. Among the
candidates, the anterior cingulate cortex (ACC) and the insular
cortex (IC) appear to be critical in the networks involved in
both pain and mood (10–12).
The ACC is a relay that interconnects neurons from the
frontal cortex, the thalamus, and the amygdala, integrating
cognitive, emotional, and autonomic functions (10,11). Clinical
imaging studies have shown the recruitment of the ACC in
pain processing (13), and preclinical studies have more
precisely associated the activation of the ACC neurons with
pain-like aversive behavior, while the inhibition of these
neurons blocks such behavior (14). The IC is another cortical
area of interest since both human and animal studies have
shown its recruitment in acute and chronic pain (15–17). The
complexity of IC connectivity and the variability of pain-relatedl ISSN: 0006-3223
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Psychiatryactivity between different IC subregions suggest that this
cortical area may play a multifaceted role in pain processing.
For example, some studies have reported a preferential
pain activation of the posterior IC (pIC) (18), whereas others
have also described it in the mid insula (19) or in the
operculoinsular area (15,20). The activation of the IC has been
implicated in both antinociceptive and pronociceptive proc-
esses (19), while its role in the aversive component of pain is
still unclear.
Despite the lack of direct evidence, the ACC and the IC
could also play a role in the anxiodepressive consequences of
chronic pain. Indeed, both cortices are known to display
functional and morphological alterations in depressive states
(21–23), such as the observation of decreased connectivity
(24), altered glucose metabolism (25), and reduced volume (26)
in the ACC of depressed patients and also altered basal
neuronal resting state activity in the IC (22). Studies showing
the alleviation of depressive symptoms in treatment-resistant
patients by ablative surgery (27) or deep brain stimulation (28)
of the ACC further support the implication of this region in
major depression. However, these data come from the psy-
chiatric ﬁeld and the involvement of these regions in the
affective consequences of chronic pain has not yet been
studied.
Although clinical and preclinical studies strongly suggest a
role of the ACC and the IC in pain processing, respective
functions of these cortical areas in the anxiodepressive
consequences as well as in the sensory and affective compo-
nents of chronic pain remain unknown. Using a lesion
approach in a murine model of neuropathic pain, we demon-
strate that the ACC is critical in the anxiodepressive con-
sequences of chronic pain, while conversely the pIC is only
critical in mechanical allodynia. The repeated stimulation of the
ACC by an optogenetic approach induces anxiodepressive
behaviors in naïve animals, which further reinforces the
essential role of this cortical region in mood disorders.METHODS AND MATERIALS
Animals
The lesion experiments were conducted in adult male C57BL/
6J mice (Charles River, L’Arbresle, France). Genetically modi-
ﬁed mice expressing channelrhodopsin-2 and yellow ﬂuores-
cent protein (Thy1-ChR2-YFP) in a subset of pyramidal
neurons were used (29) for optogenetic studies (Supplement 1).
Surgical Procedures
Chronic neuropathic pain was induced by placing a cuff
around the right common sciatic nerve (4). Bilateral excitotoxic
lesions of the ACC and the pIC by local injection of ibotenic
acid were performed under stereotaxic surgery (see
Supplement 1).
Optogenetic Procedures
Animals were anesthetized (ketamine 17 mg/mL, xylazine 2.5
mg/mL, intraperitoneal 4 mL/kg) before being placed in a
stereotaxic frame (David Kopf Instruments, Tujunga, Califor-
nia). Single glass ﬁber cannulas, 1.7 mm long with a diameterBiological Psyof 220 mm (MFC_220/250-0.66_1.7 mm_RM3_FLT, Doric
Lenses, Quebec, Canada) were implanted in the left ACC.
Coordinates derived from the Franklin and Paxinos atlas (30)
were set to .7 mm anterior and .3 mm lateral to the Bregma.
The cannula was lowered until 1.5 mm of optic ﬁber was
inserted into the brain, covering the whole vertical span of
the ACC.
After 3 to 7 days of recovery period, the ACC was
stimulated with a blue light emitting diode (LED) with a peak
wavelength of 463 nm (LEDFRJ-B_FC, Doric Lenses). From
the LED, the light traveled through the ﬁber optic patch cable
(MFP_240/250/2000-0.63_0.75m_FC_CM3) to the implant
cannula. Light pulses were generated through a universal
serial bus connected transistor-transistor logic pulse generator
(OPTG_4, Doric Lenses) connected to a LED driver
(LEDRV_2CH v.2, Doric Lenses). Transistor-transistor logic
pulses were generated by open source software developed
by Doric Lenses (USBTTL V1.9). Optical power was measured
at the ﬁber tip using a photodetector (UNO, Gentec, Quebec,
Canada).
Optogenetic stimulation took place on 4 consecutive days
for 30 minutes. Stimulated animals received repetitive stimu-
lation sequences of 10 seconds consisting of 8 seconds at 20
Hz with 40 milliseconds pulses and 2 seconds without
stimulation (31). Light intensity was measured before implan-
tation and was set between 4 mW and 5 mW. Control animals
underwent the same implant procedures but the light was
turned off during stimulation time.
Electrophysiological Recordings
Patch-clamp recordings of the ACC pyramidal neurons were
performed using acute slices prepared from 9- to 12-week-old
Thy1-ChR2-YFP mice, the ACC being illuminated with the
same system used for the in vivo experiments (Supplement 1).
Pain- and Anxiodepressive-Related Behaviors
The mechanical threshold of hindpaw withdrawal was deter-
mined using von Frey ﬁlaments (Bioseb, Chaville, France) (4),
while the spontaneous pain was evaluated using conditioned
place preference in response to the intrathecal administration
of the analgesic α2-adrenoceptor agonist clonidine (10 µg) (32)
(Supplement 1).
For lesion studies, the novelty suppressed feeding (NSF),
splash, and forced swimming tests (FST) were conducted 6, 7,
and 8 weeks after the peripheral nerve injury, respectively. For
the optogenetic studies, animals were tested with the NSF test
1 day after the last stimulation. Splash test and marble burying
test were performed the fourth and the ﬁfth days after the ﬁnal
stimulation (Supplement 1).
Immunohistochemistry, Analysis, and Illustrations
For the lesion study, after the behavioral testing, the animals
were perfused and NeuN immunostaining was performed.
Lesions were indicated by neuronal cell loss localized bilat-
erally and extended from 1.18 to .14 mm from the bregma for
the ACC lesion and from .38 to 21.22 mm from the bregma for
the pIC lesion. Concerning the optogenetic study, after the
completion of the behavioral tests, the animals were stimu-
lated once with the same procedure as described before andchiatry February 1, 2015; 77:236–245 www.sobp.org/journal 237
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Psychiatryperfused 90 minutes later. c-Fos immunohistochemistry then
allowed to control for both the implant location and the
activation of the ACC by the optogenetic procedure. Blind
veriﬁcation and lesion three-dimensional reconstructions were
done using a Nikon Eclipse 80i microscope with the Neuro-
lucida 8.0 software (MicrobrightField, Williston, Vermont).
Pictures were taken with a Nikon E80i microscope. Adobe
Photoshop CS5 (Adobe, San Jose, California) was used to
adjust contrast, brightness, and sharpness.
Statistical Analysis
Data are expressed as mean 6 SEM. Statistical analyses were
performed using multifactor analysis of variance (ANOVA) with
independent or repeated measures. In case of signiﬁcant
effect following ANOVA, multiple group comparisons were
performed with Duncan post hoc analysis. Signiﬁcance level
was set at p , .05. All the analyses were performed with
STATISTICA 7.1 (Statsoft, Tulsa, Oklahoma).B
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RESULTS
Excitotoxic Lesions of the ACC or the pIC
To concurrently analyze the role of the ACC and the pIC in the
consequences of chronic pain, we used a murine model of
chronic neuropathic pain (4) and performed localized excito-
toxic lesions of these cortices with ibotenic acid. NeuN
immunostaining allowed visualization of the extent of the
lesions at the end of the experiments (Figure 1A–C, and see
three-dimensional image in Supplement 2). To control whether
the behavioral phenotypes were independent from possible
activity deﬁcits, the spontaneous locomotor activity was
evaluated. We observed no difference between control and
neuropathic animals and no inﬂuence of the lesion on sponta-
neous activity (Figure 1D) or on body weight (Figure 1E).(days, post-surgery) 
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Figure 2. Inﬂuence of the anterior cingulate cortex (ACC) and the posterior insular cortex (pIC) on the somatosensory components of neuropathic pain.
Neuropathic animals display a unilateral increase of mechanical (A) and thermal (D) sensitivity in the right hindpaw. The lesion of the ACC has no effect on
these behaviors (B, E). The lesion of the pIC prevents the maintenance of the long-term mechanical hypersensitivity (C) without affecting short-term thermal
sensitivity (F). Data are expressed as mean 6 SEM. *p , .05, **p , .01, ***p , .001 sham versus neuropathy; n 5 10–17 animals per group for von Frey test,
n 5 5–6 animals per group for the radiant heat test.
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PsychiatryThe pIC but not the ACC Is Necessary for the
Somatosensory Component of Chronic Pain
In the neuropathic pain model, we observed decreased
mechanical sensitivity thresholds, referred to as mechanical
allodynia, by using von Frey ﬁlaments (F14,434 5 7.41,
p , .001, Figure 2A). Current preclinical data suggest different
inﬂuences of the ACC and the IC (14,16) in neuropathic
mechanical allodynia. In accordance with this prediction, we
found that while the lesion of the ACC did not affect
mechanical allodynia (F8,160 = 4.79, p , .001, Figure 2B;
F4,160 5 20.617, p , .001 Figure S2 in Supplement 1), the
lesion of the pIC completely suppressed its long-term devel-
opment (F14,420 5 9.25, p , .001; Figure 2C). More precisely,
the early postsurgical allodynia remained present in the pIC
lesioned mice during the ﬁrst 2 weeks after sciatic nerve
surgery, whereas the long-term allodynia reﬂecting the chron-
icity of this symptom was abolished. The pIC is thus a core
substrate of long-term allodynia in chronic neuropathic pain.Biological PsyHuman studies also support these results, showing that IC
subdivisions are activated by mechanical allodynia in neuro-
pathic pain (33). Clinical studies showed that the IC lesion may
modify nociceptive sensitivity in humans, but these studies
remain difﬁcult to interpret due to the interindividual variability
in the extent of the lesion (15,34). Interestingly, our results
show that neither the lesion of the ACC nor the lesion of the
pIC altered the mechanical thresholds per se in control
animals (Figure 2B,C). This suggests that neuropathic
mechanical allodynia is integrated by the pIC, being selectively
revealed under chronic pain conditions.
Thermal hyperalgesia is another sensory symptom that may
be present in neuropathic pain patients. We evaluated the role
of the ACC and the pIC by using the radiant heat paw-
withdrawal test. Similar to mechanical allodynia, neither the
ACC nor the pIC lesion modiﬁed the thermal sensitivity in
control animals or the hypersensitivity observed during the
early phase of the neuropathy (12 days postsurgery)
(Figure 2D–F, lesion 3 surgery F2,27 5 .09, p 5 .91). Inchiatry February 1, 2015; 77:236–245 www.sobp.org/journal 239
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Psychiatryaddition, the lesion of the targeted cortical areas had no
effect on the thermal sensitivity in the later phase of the
neuropathy (46 days postsurgery) when thermal hyperalgesia
was no longer present in the neuropathic animals (data not
shown).
The ACC but not the pIC Is a Core for the
Anxiodepressive Consequences of Chronic Pain
The above data revealed a distinct role of the ACC and the pIC
in the sensory components of neuropathic pain. It was then
of interest to determine the implication of these cortices in
the anxiodepressive consequences of neuropathic pain. We
observed the anxiodepressive-like behaviors accompanying
chronic pain through the increased latency to ﬁrst bite in the
novelty suppressed feeding test (two-way ANOVA; lesion 3
surgery F2,62 5 5.70, p , .01; no lesion sham , cuff, p , .002;
Figure 3A), the decreased grooming duration in the splash test
(F2,81 5 3.796, p , .02; no lesion sham . cuff, p , .001;
Figure 3B), and the prolonged immobility in the forced swim-
ming test (F2,78 5 10.24, p , .001; no lesion sham , cuff,
p , .001; Figure 3C). In the NSF test, which relies on both
anxiety- and depression-like aspects, the lesion of the ACC (p 5
.65) but not the pIC (p , .001; Figure 3A) suppressed the
chronic pain-induced delayed latency to feed. Similarly,
depressive-like behaviors observed in neuropathic animals wereNSF
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Figure 3. Inﬂuence of the anterior cingulate cortex (ACC) and the
posterior insular cortex (pIC) on the anxiodepressive consequences of
neuropathic pain. An increased latency to feed in the novelty suppressed
feeding (NSF) test (A), a decrease in the grooming behavior in the splash
test (B), and an increase in the immobility duration in the forced swimming
test (FST) (C) are observed in neuropathic mice compared with control
mice. While these effects are prevented by the ACC lesion (A–C), the lesion
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neuropathic mice (A–C). Data are expressed as mean 6 SEM. ***p , .001
sham versus neuropathy. The number of animals per group is indicated on
the bar graphs.
240 Biological Psychiatry February 1, 2015; 77:236–245 www.sobp.orprevented by the lesion of the ACC (p 5 .55) but not the pIC in
the splash test (p , .01; Figure 3B) and the FST (for the ACC p
5 .22, for the pIC p , .001; Figure 3C). The lesion of either the
ACC or the pIC had no effect per se on the behavioral tests in
control animals (for NSF, ACC p 5 .91, pIC p 5 .71; for splash
test, ACC p 5 .16, pIC p 5 .37; for FST, ACC p 5 .95, pIC p 5
.72; Figure 3A–C). These data, to the best of our knowledge, are
the ﬁrst evidence showing that the ACC is a hub for the
anxiodepressive consequences observed in chronic pain.
The Optogenetic Stimulation of the ACC Induces
Anxiodepressive-like Behavior
Since the ablation of the ACC blocked the anxiodepressive-
like behaviors induced by chronic pain, we wondered
whether an activation of this structure could induce
depressive-like behavior. We thus performed sustained opto-
genetic stimulation of the pyramidal neurons of the ACC
using naïve Thy1-ChR2-YFP mice (Figure 4A). The functional
validation of ChR2-YFP expression using ex vivo electro-
physiological recordings conﬁrmed that the optogenetic
stimulation reliably enables trigger action potential ﬁring of
the ACC pyramidal neurons (Figure 4C,D). In vivo, we also
observed that the ACC optogenetic stimulation led to a
robust induction of c-Fos compared with control mice (F1,9
5 16.3, p , .01; Figure 4B). Behavioral results showed that
the repeated activation of the ACC induces anxiodepressive
behavior (Figure 4F) in naïve animals without affecting
mechanical threshold (F1,10 5 .2 p 5 .66; Figure 4E). Indeed,
the stimulated animals displayed an increased latency to ﬁrst
bite in the NSF test (F1,16 5 28.88, p , .001; Figure 4F) and a
decrease in overall grooming time (F1,15 5 13.01, p , .01;
Figure 4F) and buried more marbles in the marble burying test
(F1,13 5 7.45 p , .05; Figure 4F). These data conﬁrm the
major role of the ACC in mood disorders.
Spontaneous Pain Remains Present in the Absence
of Allodynia After pIC Lesion
Clinically, the presence of spontaneous pain is often more
debilitating than the alteration of evoked nociceptive
responses. For a long time, this parameter had remained
elusive in animal research. Recently, it has been shown that
such spontaneous pain can be unmasked in animal models
of neuropathic pain (32) by relieving the tonic-aversive state
in chronic pain thanks to nonrewarding analgesic drugs. The
cerebral network mediating the aversive component of pain
includes the ACC (14,35), but its connections with somato-
sensory pain pathways are poorly described, while its
relations with anxiodepressive behaviors remain unknown.
We thus compared the role of the ACC and the pIC in the
spontaneous pain component of neuropathic pain 10 weeks
after the induction of peripheral nerve injury, using the
conditioned place preference (CPP) paradigm. Our results
showed that the analgesic effect of clonidine was not
affected by the ACC or the pIC lesions (lesion 3 surgery
3 treatment, F2,24 = .38, p = .68; Figure 5A). Following spinal
clonidine administration (10 mg) at the level of the lumbar
spinal cord, we observed a CPP in neuropathic animals
(surgery 3 treatment, F1,42 5 6.7, p , .05; Figure 5B),
resulting from pain relief. This effect of clonidine was notg/journal
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Figure 4. Inﬂuence of the optogenetic stimulation of the anterior cingulate cortex (ACC) on anxiodepressive-like behaviors. (A) Representative picture of the
ACC in the Thy-1-ChR2-YFP mice. (B) Stimulation of the ACC induces local c-Fos expression. (C) Luminance-response curve of the light-evoked currents
recorded in the voltage-clamp mode in the ACC pyramidal neurons of Thy-1-ChR2-YFP mice (top: representative trace; bottom: n 5 6). The maximal
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the ACC had no effect on mechanical sensitivity. (F) Repeated activation of the ACC increased the latency to feed in the novelty suppressed feeding (NSF)
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Psychiatrypresent in sham mice, supporting the idea that this drug
selectively unmasked the tonic-aversive state in chronic
pain. Pain relief CPP was still present after pIC lesion
(surgery 3 treatment, F1,44 5 4.3, p , .05; Figure 5D),
showing that spontaneous pain arising from injured nerveBiological Psyﬁbers was still present even though mechanical allodynia
was suppressed in these animals (Figure 2C). The lesion
of the ACC (surgery 3 treatment, F1,46 5 .42, p 5 .52;
Figure 5C) blocked the pain relief CPP, in agreement with a
previous report in rats (35).chiatry February 1, 2015; 77:236–245 www.sobp.org/journal 241
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Figure 5. Inﬂuence of the anterior cingulate cortex (ACC) or the posterior
insular cortex (pIC) on conditioning to spontaneous pain relief. (A) Intrathe-
cal injection of clonidine (10 mg) induced analgesia in each experimental
group. (B) Intrathecal clonidine (10 mg) increased the time spent in the
paired chamber, with a corresponding decrease in the saline-paired
chamber, in neuropathic but not sham-operated mice. The lesion of the
ACC (B) but not the pIC (C) blocked the clonidine-induced conditioned
place preference in neuropathic animals. Data are expressed as mean 6
SEM. *p , .05 saline paired versus clonidine paired. For the assessment of
analgesic effects of clonidine, n 5 5 per group. For conditioned place
preference experiments, n 5 10–14 per group.
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Our ﬁndings show that the sensory component of chronic pain
is functionally dissociated from its affective and anxiodepres-
sive components and that the ACC is a critical brain region for
the latter. Indeed, the presence of the ACC is necessary for the
anxiodepressive consequences of chronic pain, while the pIC
is important only for the somatosensory component. Our242 Biological Psychiatry February 1, 2015; 77:236–245 www.sobp.oroptogenetic study further supports the role of the ACC in
mood disorders by showing that repeated sessions of ACC
stimulation induces anxiodepressive behavior.
Besides chronic stress, chronic pain is another risk factor
for depression. However, it differs from chronic stress, as
neuropathic pain does not induce alterations of the HPA axis
(4,7). In the present study, we showed that the ACC is a critical
brain region for the neuropathic pain-induced depression. The
ACC has been implicated in the pathophysiology of depres-
sion since imaging studies have shown hypoactivity in the
dorsal portions of the ACC, hyperactivity in its ventral regions
(36), and a reduced volume of the ACC (26) in depressed
patients. This notion is further supported by preclinical studies
showing that the social-defeat paradigm is accompanied by
increased cingulate activity (37). Preclinical studies showed
that the ACC is also affected by chronic pain. Indeed, chronic
pain can induce functional alterations, such as decreased
long-term depression (38) or triggered synaptic potentiation,
implicating both presynaptic enhancement of glutamate
release and postsynaptic potentiation of α-amino-3-hydroxy-
5-methyl-4-isoxazole propionic acid (AMPA) receptor-
mediated responses in the ACC (39). However, the functional
role of the ACC in the consequences of chronic pain remains
still unexplored. In this context, our results provide a causal
link between the ACC and the development of anxiodepres-
sive symptoms following chronic pain.
By using the optogenetic approach, we showed that
repeated stimulation of pyramidal neurons in the ACC
provokes anxiodepressive-like behavior. This ﬁnding may
contrast with a previous report of medial prefrontal cortex
stimulation that induced antidepressant-like effect (40); how-
ever, this study was conducted in the prelimbic and infra-
limbic regions of the medial prefrontal cortex, rather than in
the ACC, with behavioral experiments performed during the
optogenetic stimulation itself. In the present study, we
stimulated the ACC only, and tests were performed after
the completion of the repeated stimulation. Our results also
showed that the anxiodepressive-like effect persists several
days after the end of the stimulation, suggesting the impli-
cation of possible neuroplastic mechanisms. As the ACC is
also the core of the aversive component of pain (14,35)
(present study), it is possible that the anxiodepressive
behaviors observed in neuropathic animals are triggered by
the affective component of pain rather than the somatosen-
sory component. Indeed, the affective response to acute pain
has an adaptive function, favoring associative learning to
avoid re-exposure to harmful stimuli or situations. However,
with chronic pain, such sustained emotional response may
participate to disadaptation of the affective systems. This
hypothesis is supported by our results showing that the
lesion of the ACC also blocked the relief of spontaneous pain
in neuropathic animals. In this study, the CPP paradigm is
used to unmask the tonic aversive state due to nonevoked
ongoing pain. In this regard, a nonrewarding analgesic drug
(i.e., intrathecal clonidine) induces a place preference when it
suppresses the spontaneous pain in the paired compartment,
thus revealing that the animal was in a spontaneous (unpro-
voked) pain state in the other compartment (32). The lesion of
the ACC prevents this preference for the intrathecal
clonidine-paired side, which could be due to the loss of theg/journal
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analgesic action of clonidine, a reduced rewarding effect of
pain relief, or to an impaired conditioning. Here, we show that
clonidine antiallodynic action remains intact after the ACC
lesion (Figure 2C). Moreover, previous studies showed that
the lesion of the ACC did not prevent cocaine-induced place
preference (35) or κ-opioid receptor agonist-induced place
aversion (14), suggesting that this part of the prefrontal
cortex may not be critical for conditioning per se. These data
may thus be supportive of a role of the ACC in the aversive
aspect of spontaneous pain (35), but further investigation will
be required to reach conclusion.
The lesion of the pIC had no effect on the anxiodepres-
sive consequences and on the spontaneous pain compo-
nent of neuropathic pain. However, a clinical study suggests
a correlation between the activation of insula and the
unpleasantness of tonic pain stimulus (41), and a recent
preclinical study showed increased cerebral blood ﬂow in
the anterior part of insular cortex during anxiety-like behav-
iors (42). These observations differ in many variables from
present work, such as the type of stimulus (acute versus
chronic) or the targeted insular cortex subregion (anterior
versus posterior). Indeed, it has been suggested that the
posterior division of the insula is involved in somatosensory
processing, while the anterior insula codes higher level
cognition/emotion related sensory modalities (43,44). Imag-
ing (45) and lesion (16) studies showed that besides the
somatosensory cortex II, the insula—especially its posterior
part—is one of the main brain regions involved in mechan-
ical allodynia. In addition to the direct projection from the
spinothalamic pathway, it also receives information from the
somatosensory cortex and it projects to the striatal com-
plex. Our results showing the pIC ablation blocked the long-
term development of mechanical allodynia further reinforce
the essential role of the pIC in this sensory symptom. While
present and previous studies (14,35,46) report that the
lesion of the ACC has no effect on nociceptive thresholds
or on allodynia, it should be acknowledged that an acute
manipulation of this brain area has been reported to induce
a transitory decrease in mechanical allodynia at early time
points after nerve injury (38).
The nociceptive information is transmitted to the brain by
various parallel ascending pathways, such as the spinopontine,
the spinomesencephalic, and the spinothalamic pathways (47).
These pathways are not fully independent, as they polysynap-
tically terminate in cortical regions that can be interconnected.
They thus participate in higher integration of nociceptive inputs
creating the complex sensory and emotional experience con-
stituting pain. In such context of brain circuitry, however, our
results support the idea that at cortical level, the sensory
component of chronic pain remains functionally dissociated
from its affective and anxiodepressive components. This func-
tional segregation that is observed between the ACC and the
pIC may rely on differences in respective connectomes.
Indeed, even though the ACC and the IC share several
common inputs and outputs, such as the paracentral, the
intermediodorsal, and the central lateral nuclei of the thalamus
(48), these cortical areas also have distinct afferents and
efferents. For example, the central medial thalamus projects
only to the ACC, but not to the IC, and the ACC sendsBiological Psyprojections to the basolateral, but not to the central amygdala,
while the pIC preferentially innervates the central amygdala
(49–51). A network level of analysis would thus be important to
further understand this functional segregation.
In control animals, the lesion of either the ACC or the pIC
had no detectable effect. This observation is in agreement with
previous ﬁndings showing a lack of effect of the ACC lesion on
the anxiodepressive-like behavior in naïve rats (52). However,
it has been reported that more rostral lesions of the ACC can
diminish per se the immobility time in the FST (53), which
should warrant more detailed studies of the relation between
ACC subregions and anxiodepressive behaviors.
In conclusion, this study supports the idea that the ACC
and the pIC are integrally involved in pain processing, but our
ﬁndings go beyond this general assertion by providing direct
side-by-side evidence for the cortical dissociation between
pain components. Importantly, it reveals the critical role of the
ACC, but not the pIC, in encoding anxiodepressive conse-
quences of chronic pain. Our optogenetic study further
reinforces the essential role of the ACC in mood disorders.
The ACC may thus constitute a primary target for unveiling the
precise cellular and molecular bases of the changes occurring
in chronic pain-induced depression.ACKNOWLEDGMENTS AND DISCLOSURES
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The Anterior Cingulate Cortex is a Critical Hub for Pain-Induced Depression 
 
Supplemental Information 
 
 
 
Supplemental Methods & Materials 
 
Animals 
All the Thy1-ChR2-YFP mice were produced onsite from breeders provided by Jackson 
Laboratory. Experiments started with 8 to12 week-old mice, group-housed five per cage and kept 
under a 12-hour light/dark cycle with food and water available ad libitum. For optogenetic studies 
only, mice were separated after the cannula implantation to avoid possible damage to the implant. 
Animal facilities are registered for animal experimentation (Agreement C67-482-1). The protocols 
were approved by the local ethical committee of the University of Strasbourg (CREMEAS, n°AL-
04). 
 
Excitotoxic Lesion 
Animals were anesthetized with an intraperitoneal injection of sodium pentobarbital (63 mg/kg, 
0.035 ml) and installed in a stereotaxic frame (Kopf, Tujunga, CA). Either ibotenic acid (56.7 mM, 
Biotrend, Köln, Germany) or PBS (1X, Euromedex, Souffelweyersheim, France) was bilaterally 
injected into the anterior cingulate cortex (ACC) (0.3 µl; anteroposterior: +0.7 mm from bregma, 
lateral: ±0.3 mm, dorsoventral: -1.7 mm from the skull) or to the pIC (0.2 µl; anteroposterior: +0.2 
mm, lateral: ±3.8 mm, dorsoventral: -4 mm) using a 5 µl Hamilton syringe (0.1 µl/minute). The 
needle remained in place for a further 5 minutes before removal. Following surgery, animals were 
left undisturbed for one week before peripheral nerve injury. 
 
Neuropathic Pain Model 
Chronic neuropathic pain was induced by placing a cuff around the right common sciatic nerve 
(1). Before surgery, mice were assigned to experimental groups so that these groups did not 
initially differ for the mechanical nociceptive threshold or for body-weight. Surgery was performed 
under ketamine/xylazine anesthesia (ketamine 17 mg/ml, xylazine 2.5 mg/ml; intraperitoneal, 
4 ml/kg) (Centravet, Taden, France). The common branch of the right sciatic nerve was exposed 
and a 2 mm section of split PE-20 polyethylene tubing (Harvard Apparatus, Les Ulis, France) was 
placed around it for the Cuff group. The Sham group underwent the same procedure without cuff 
implantation. 
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Preparation of Acute Slices 
Mice, 9-12 weeks old, were killed by decapitation. The brain was removed and immediately 
immersed in cold (0-4°C) sucrose-based artificial cerebrospinal fluid containing (in mM): 248 
sucrose, 11 glucose, 26 NaHCO3, 2 KCl, 1.25 KH2PO4, 2 CaCl2 and 1.3 MgSO4 (bubbled with 
95% O2 and 5% CO2). Transverse slices (400 μm thick) were performed with a vibratome 
(VT1000S, Leica, Nussloch, Germany). Slices were maintained at room temperature in a chamber 
filled with artificial cerebrospinal fluid containing (in mm): 126 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 
NaH2PO4, 2 CaCl2, 2 MgCl2 and 10 glucose (bubbled with 95% O2 and 5% CO2; pH 7.3; 
310 mOsm measured). 
 
Electrophysiological Recordings 
Slices were transferred to a recording chamber and continuously superfused with oxygenated 
artificial cerebrospinal fluid. Pyramidal ACC neurons were recorded in the whole-cell 
configuration. Patch pipettes were pulled from borosilicate glass capillaries (Harvard Apparatus, 
Edenbridge, UK) using a P-2000 puller (Sutter Instruments, Novato, CA, USA). They were filled 
with a solution containing the following (in mm): 145 KCl, 10 HEPES and 2 MgCl2 (pH 7.3, 
adjusted with KOH; osmolarity 310 mOsm adjusted with sucrose) (3.5–4.5 MΩ). All recordings 
were performed in presence of CNQX (10 µM) and bicuculline (10 µM). Voltage-clamp and 
current-clamp recordings were performed with an Axopatch 200B amplifier (Molecular Devices, 
Union City, CA, USA) at a holding potential fixed at −60 mV or a holding current allowing 
maintaining the resting neuron at ca. -60 mV. Recordings were acquired with WinWCP 4.3.5 
(courtesy of Dr. J. Dempster, University of Strathclyde, Glasgow, United Kingdom). All recordings 
were performed at 34°C. The ACC was illuminated with the same system used for the in vivo 
experiments (see below) triggered with WinWCP 4.3.5, the optic fiber being localized in the 
recording chamber at 3 mm from the recorded neuron.  
 
Nociceptive Tests 
The mechanical threshold of hindpaw withdrawal was evaluated using von Frey hairs (Bioseb, 
Chaville, France) (1). Mice were placed in clear Plexiglas® boxes (7 x 9 x 7 cm) on an elevated 
mesh screen and allowed to habituate for 15 minutes before testing. Filaments were applied to the 
plantar surface of each hindpaw in a series of ascending forces (0.16 to 15 grams). Each filament 
was tested five times per paw, being applied until it just bent, and the threshold was defined as 3 
or more withdrawals observed out of the 5 trials. All animals were tested before and after the 
lesion and every week after the neuropathic pain induction. The latency for hindpaw withdrawal in 
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response to thermal stimulation was determined using the Hargreaves method (2). Mice were 
placed in clear Plexiglas boxes (7 cm × 9 cm × 7 cm) on a glass surface, and were allowed to 
habituate for 15 minutes before testing. The infrared beam of the radiant heat source (7370 
Plantar Test; Ugo Basile, Comerio, Italy) was applied to the plantar surface of each hind paw. The 
cutoff to prevent damage to the skin was set at 15 seconds. Paw withdrawal latency were 
measured twice for each hind paw. The animals were tested 12 days and 46 days after the 
neuropathic pain induction. 
 
Place Conditioning 
All experiments were conducted by using the single trial conditioned place preference (CPP) 
protocol as described previously for rats (3). The apparatus (Imetronic, Pessac, France) consists 
of 3 Plexiglas chambers separated by manually operated doors. Two chambers (size 15 cm x 24 
cm x 33 cm) distinguished by the texture of the floor and by the wall patterns are connected by a 
central chamber (size 15 cm x 11 cm x 33 cm). Eight to ten weeks after the Cuff/Sham surgery, 
mice went through a 3-day pre-conditioning period with full access to all chambers for 30 minutes 
each day. Time spent in each chamber was analyzed to control for the lack of spontaneous 
preference for one of the compartments. Animals spending more than 75% or less than 25% of 
the total time in one of the lateral chambers were removed from the study. On the conditioning 
day (day 4), mice first received intrathecal saline (10 µl) and were placed in a conditioning 
chamber. Four hours later, mice received intrathecal clonidine (10 µg / 10 µl) and were placed in 
the opposite chamber. Clonidine, an α2-adrenoceptor agonist, induces analgesia after intrathecal 
administration. Conditioning sessions lasted 15 minutes each, without access to the other 
chambers. On the test day (day 5, 20 hours after the last afternoon session), mice were placed in 
the center chamber with free access to all chambers and the time spent in each chamber was 
recorded for 30 minutes. With this procedure, CPP is the consequence from combined 
spontaneous pain-induced aversion to the unpaired side and spontaneous pain relief-induced 
reward in the clonidine paired side. The clonidine was administered intrathecally as described 
previously (4) for both CPP experiments and for testing its analgesic effect with von Frey 
filaments. 
 
Locomotor Activity  
Five to six weeks after induction of neuropathic pain, locomotor activity was monitored for both 
sham and neuropathic mice. Mice were individually placed in activity cages (32 x 20 cm floor area, 
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15 cm high) with 7 photocell beams. The number of beam breaks was recorded over 4 hours. The 
results were presented with 1 hour interval. 
 
Anxiodepressive-Related Behavior  
Behavioral testing was performed during the dark phase, under red light. While each mouse 
went through different tests, these were conducted according to the following rules: 1) at least one 
week separated 2 tests done on the same animal; 2) no mouse went through the same test twice; 
3) the forced swimming test (FST) was always considered as terminal (i.e. no other test was done 
on mice after they went through forced swimming). Body weights were measured weekly. 
 
Novelty Suppressed Feeding Test. The testing apparatus consisted of a 40 x 40 x 30 cm 
plastic box with the floor covered with 2 cm of sawdust. Twenty four hours prior to the test, food 
was removed from the home cage. At the time of testing, a single pellet of food was placed on a 
paper in the center of the box. An animal was then placed in a corner of the box and the latency to 
eat the pellet was recorded within a 5 minute period. This test induces a conflict between the drive 
to eat the pellet and the fear of venturing into the center of the box (5). The test was conducted 6 
weeks after the peripheral nerve injury for the lesion study and one day after the last stimulation 
for the optogenetic study. 
 
Splash Test. This test, based on grooming behavior, was performed as previously described 
(5, 1). The duration of grooming behavior was measured during 5 minutes after spraying a 10% 
sucrose solution on the dorsal coat of the mice. Grooming is an important aspect of rodent 
behavior and decreased grooming in this test may be related to the loss of interest in performing 
self-oriented minor tasks (6). The test was performed 7 weeks after the peripheral nerve injury for 
the lesion study and four days after the last stimulation for the optogenetic study. 
 
Forced Swimming Test. FST (7) was conducted by gently lowering the mouse into a glass 
cylinder (height 17.5 cm, diameter 12.5 cm) containing 11.5 cm of water (23-25°C). Test duration 
was 6 minutes. The mouse was considered immobile when it floated in the water, in an upright 
position, and made only small movements to keep its head above water. Since little immobility 
was observed during the first 2 minutes, the duration of immobility was quantified over the last 4 
minutes of the 6 minutes test. The test was done 8 weeks after the peripheral nerve injury. 
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Marble Burying Test. This test was done in Plexiglas cages (27 x 16 x 14 cm) containing 3 cm 
of fine sawdust. Twenty five glass marbles (1 cm diameter) were evenly spaced on top of the 
sawdust. Mice were placed individually into the cages and left undisturbed for 30 min. They were 
then removed and an observer blind to the condition of the animals counted the buried marbles. 
Marbles were considered buried if two-thirds, or more, of their surface was covered by sawdust. 
The number of buried marbles is a measure of animal anxiety (8-10). The test was performed 5 
days after the last optogenetic stimulation. 
 
Immunohistochemistry 
For the lesion study, after the last behavioral testing the animals were perfused under deep 
sodium pentobarbital anesthesia (273.5 mg/kg; 0.15 ml) with 10 ml phosphate buffer (PB, 0.1 M, 
pH 7.4) followed by 100 ml of a paraformaldehyde solution (4% in phosphate buffer). Brains were 
removed and post-fixed overnight in the same fixative. Frontal sectioning of the brain (40 μm) was 
performed on a vibratome (Leica, Rueil-Malmaison, France). For NeuN immunostaining, sections 
were washed in PBS (3 x 10 minutes), incubated 15 minutes in a 1% H2O2 / 50% ethanol solution, 
washed in PBS (3 x 10 minutes) and pre-incubated in PBS containing Triton X-100 (0.3%) and 
5% donkey serum for 45 minutes. Sections were then incubated overnight at room temperature in 
PBS containing Triton X-100 (0.3%), 1% donkey serum and a mouse anti-NeuN primary antibody 
(1:50000; Millipore, MAB377, Molsheim, France). Sections were then washed in PBS (3 x 10 
minutes), incubated with a biotinylated horse anti-mouse secondary antibody (1:200 in PBS 
containing Triton X-100, 1% donkey serum) for 90 minutes, washed in PBS (3 x 10 minutes) and 
incubated with PBS containing the avidin-biotin-peroxidase complex (ABC kit; 0.2% A and 0.2% 
B; Vector laboratories) for 90 minutes. After being washed in Tris-HCl buffer, sections were 
incubated in 3,3’diaminobenzidine tetrahydrochloride (DAB) and H2O2 in Tris-HCl for 
approximately 4 minutes and washed again. Sections were serially mounted on gelatine-coated 
slides, air dried, dehydrated in graded alcohols, cleared in Roti-Histol (Carl Roth, Karlsruhe, 
Germany) and coverslipped with Eukitt. Lesions were indicated by neuronal cell loss localized 
bilaterally and extended from 1.18 to 0.14 mm from the bregma for ACC lesion and from 0.38 to    
-1.22 mm from the bregma for pIC lesion. 
Concerning the optogenetic study, after the completion of the behavioral tests the animals 
were stimulated once with the same procedure as described before. Ninety minutes later the 
animals were perfused and c-Fos immunohistochemistry was performed. This was done to check 
the implant location and the presence of c-Fos, a biomarker for neuronal activity. For c-Fos 
immunostaining, the procedure used was the same as that described for NeuN immunostaining. 
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The primary antibody was a rabbit anti-c-Fos (1:10000; Santa Cruz Biotechnology, E1008) and a 
biotinylated donkey anti-rabbit secondary antibody (1:300 in PBS containing Triton X-100, 1% 
donkey serum). Animals having c-Fos induction outside of the ACC, for instance in the motor 
cortex, were excluded from analysis. 
 
 
 
 
 
 
 
Figure S1. 3D representation of the lesions of the anterior cingulate cortex (ACC) and the 
posterior insular cortex (pIC). Borders of the brain are colored in green, corpus callosum and 
external capsule in yellow, anterior commissure and fornix in orange, lateral and third ventricles in 
blue and the lesions of the ACC and the pIC in magenta. These 3D images are available as 
separate supplemental files. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Influence of the anterior cingulate cortex (ACC) on the mechanical threshold. The 
lesion of the ACC has no effect on the increased mechanical sensitivity observed in neuropathic 
animals. This experiment was done independently from the one presented in Figure 2. Data are 
expressed as mean ± SEM. ***p < .001 Neuropathy versus Sham. 
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Introduction 
Mood disorders, such as depression and anxiety, are frequently observed in patients suffering 
from chronic pain and add dramatically to the patients’ pain burden (1). Preclinical studies 
showed that the anxiodepressive consequences of long term chronic pain, such as neuropathic 
pain, can be studied in murine models (2-4) and develop in a time-dependent manner (3, 9). 
Interestingly, mood disorders remain present 2 weeks after recovery from evoked 
hypersensitivity in an animal model of neuropathic pain (517), which raises the question whether 
the anxiodepressive consequences of pain are maintained independently from these sensory 
changes. 
 The anterior cingulate cortex (ACC), one of the brain regions implicated in chronic pain-
induced mood disorders, is involved in the processing of both pain and mood-related information 
(6, 7). For instance, both the presence of ACC hyperactivity in depressed patients (315-317), and 
ACC transcriptome changes in mice with depressive-like behavior induced by the unpredictable 
chronic mild stress model (518), support the implication of the ACC in depression. On the other 
hand, clinical imaging studies show the recruitment of the ACC in pain processing (519), and 
preclinical studies more precisely associate the activation of ACC neurons with pain-like aversive 
behavior (9, 492). Furthermore, disinhibition (47) and increased excitability (520, 521) are also 
observed ex vivo in the ACC from rodent’s models of chronic pain. The implication of the ACC 
is also supported by in vivo studies showing that a lesion of the ACC prevents both chronic pain-
induced depression (9) and the aversiveness of spontaneous pain, without affecting mechanical 
sensitivity (9, 492, 513, 514). Lastly, optogenetic activation of pyramidal neurons within the 
ACC is sufficient to induce anxiety and depressive-like behavior in naive mice (9). 
 In the present study, we first aimed to characterize the long term evolution of the sensory, 
the aversive and the anxiodepressive consequences of neuropathic pain in mice. In addition, 
53  
 
within this 6 month time-course, we determined the in vivo electrophysiological alterations of the 
ACC accompanied by these various symptoms, and correlated them to different stages of the 
pathology. 
 Behaviorally, we show the existence of long-term symptom inertia of evoked 
hypersensitivity, aversions towards spontaneous pain, and anxiety/depressive-like consequences 
of neuropathic pain. These symptoms appear and disappear sequentially, with a temporal 
association between the aversive and depressive aspects. The in vivo electrophysiological 
recordings further show that ACC hyperactivity is correlated with the aversive and 
anxiodepressive consequences. This is further supported by ex vivo patch clamp recordings 
highlighting facilitation of excitatory, but not inhibitory, synaptic transmission onto ACC 
pyramidal neurons. Moreover, we show that the optogenetic inhibition of the ACC is sufficient to 
counteract the chronic pain-induced aversive and anxiodepressive-like phenotypes, which further 
supports a causal link between ACC hyperactivity and the affective aspects of neuropathic pain. 
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Methods 
Animals 
Experiments were conducted using male adult C57BL/6J (Charles River, L’Arbresle, France). All 
animals were group-housed with a maximum of five animals per cage and kept under a reversed 
12-hour light/dark cycle. Only the animals used for the optogenetic experiments were single 
housed to avoid possible damage to the implant. All behavioral experiments were conducted 
during the dark phase under red light. The Chronobiotron animal facilities are registered for 
animal experimentation (Agreement A67-2018-38) and protocols were approved by the local 
ethical committee of the University of Strasbourg (CREMEAS, nº 02015021314412082). 
 
Surgical procedures 
Surgical procedures were done under ketamine/xylazine anesthesia (ketamine 17 mg/ml, xylazine 
2.5 mg/ml; intraperitoneal, 4 ml/kg) (Centravet, Taden, France). 
 
Neuropathic pain model 
Neuropathic pain was induced by implanting a 2mm section of PE-20 polyethylene tubing 
(Harvard Apparatus, Les Ulis, France) around the main branch of the right sciatic nerve (522). 
Before the surgery, animals were assigned to experimental groups according to their initial 
mechanical nociceptive threshold, in order to even out the average mechanical threshold among 
groups. Animals in the sham condition underwent the same procedure without cuff implantation.  
 
Virus injection 
After anesthesia, C57BL/6J mice were placed in a stereotaxic frame (Kopf, Tujunga, CA) and 0.5 
µl of AAV5-CaMKIIa-eArchT3.0-EYFP (UNC vector core) was injected bilaterally in the ACC 
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(areas 24a/24b) using a 5 µl hamilton syringe (0.05 µl/minute, coordinates for the ACC: +0.7 mm 
from bregma, lateral: ±0.3 mm, dorsoventral: -1.5 mm from the skull). After injection, the needle 
remained in place for 10 minutes before removal and then the skin was sutured.  
 
Optic fiber cannula implantation 
Four weeks (w) after virus injection, the animals underwent optic fiber cannula implantation. The 
mice were implanted unilaterally over the site of virus injection. Cannulas were implanted in the 
left hemisphere in half of each experimental group, whereas the other half received the implant in 
the right hemisphere. The optic fiber cannula was 1.7 mm long and 220 µm in diameter. The 
cannula was inserted 1.5 mm deep in the brain (MFC_220/250-0.66_1.7mm_RM3_FLT, Doric 
Lenses).  
 
Optogenetic procedures 
After a 3 to 7 days recovery period, we performed behavioral experiments. Green laser light 
(custom assembly, Green 520 nm, 50 mW, Miniature Fiber Coupled Laser Diode Module, Doric 
Lenses) was delivered through a 0.75 m long monofiber optic patch chord (MFP_240/250/2000-
0.63_0.75m_FC-CM3, doric lenses) that was mounted to the optic fiber implant on the skull. 
Optogenetic inhibition was done either before or during behavioral testing, by emitting 
continuous light for 5 minutes with a power of 16 mW. Control animals underwent the same 
procedures but the light was turned off during stimulation procedures. 
 
Behavioral analysis 
Nociceptive testing 
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Von Frey filaments were used to determine the mechanical threshold of hindpaw withdrawal 
(Bioseb, Chaville, France). Mice were placed in Plexiglas® boxes (7 cm x 9 cm x 7 cm) on an 
elevated mesh screen. After 15 minute habituation, animals were tested by applying a series of 
ascending forces (0.16 to 15 grams) on the plantar surface of each hind paw. Each filament was 
tested 5 times per paw, applied until it just bent. The threshold was defined as 3 or more 
withdrawals observed out of the 5 trials. In order to characterize changes in mechanical 
thresholds during an extended period, we tested animals before and 1, 3, 5, 6, 12, 15, 16, 18, 19 
and 21 w after sciatic nerve surgery. The animals used for optogenetic inhibition of the ACC 
were tested before sciatic nerve surgery and before the behavioral tests (8 and 14 w after the 
surgery). Finally, we tested the animals during the stimulation to see whether optogenetic 
inhibition affected mechanical thresholds. 
 
Conditioned place preference 
In order to evaluate spontaneous pain, the single trial conditioned place preference (CPP) 
paradigm was used (513). For this, we used an apparatus consisting of 3 Plexiglas® chambers 
separated by manually operated doors (Imetronic, Pessac, France). Two chambers (15cm x 24cm 
x 33cm), distinguishable by the texture of the floor and by the wall patterns, are connected by a 
central chamber (15cm x 11cm x 33cm). Animals went through a 3-day preconditioning period 
during which they had access to all chambers for 30 minutes each day. Time spent in each 
chamber was analyzed to control for the lack of spontaneous preference for one of the 
compartments. Animals that spent more than 75% or less than 25% of the total time in one of the 
chambers were removed from the study. On the conditioning day (day 4), mice first received 
intrathecal saline (10 μl) and were placed in a conditioning chamber. Four hours later, mice 
received clonidine (10 μg/10 μl), an α2-adrenoceptor agonist which induces analgesia after 
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intrathecal administration, and were placed in the opposite chamber. Conditioning lasted 15 
minutes per compartment, without allowing the animal to access the other chambers. On the fifth 
day, mice were placed in the center chamber with free access to both conditioning chambers and 
the time spent in each chamber was recorded for 30 minutes. CPP was assessed for different 
batches of animals corresponding to 8, 14 and 22 w after the sciatic nerve injury. 
 In order to study, whether optogenetic inhibition of the ACC causes a preference, we used 
another version of the CPP test. For this test, we used a custom made box with 2 chambers (23cm 
x 22cm x 16cm), distinguishable by different wall patterns, connected with each other by a single 
sliding door. The test lasted four days. On the first day, animals were habituated to the testing 
box by allowing full access to both compartments for 5 minutes. During the second and third day, 
animals went through a conditioning period. For this purpose, during the mornings, the animals 
were placed in the compartment where they received no stimulation, while during the afternoon 
sessions they were stimulated following the above mentioned protocol. Control animals 
underwent the same procedures but during the afternoon phase the laser light remained off. On 
the fourth day we placed the animal at the level of the sliding door and measured the time spent 
in each compartment during 5 minutes.  
 
Dark-light test 
In order to measure anxiety-like behavior, we performed the dark-light test (523), with a two 
compartment testing box (18cm x 18cm x 14.5cm) connected by a dark tunnel (8.5cm x 7cm x 
6cm). One compartment was brightly illuminated (1500 lux) whereas the other was dark. Mice 
were placed in the dark compartment in the beginning of the test and the time spent in the lit 
compartment was recorded for 5 minutes. This test was done 8 and 15 w after sciatic nerve 
surgery in different sets of animals. 
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Novelty suppressed feeding test  
The novelty suppressed feeding (NSF) test was used to assess anxiodepressive-like behavior as it 
induces a conflict between the drive to eat and the fear of venturing into the center of the box 
(524). For this test, we used a 40cm x 40cm x 30cm plastic box with the floor covered with 2 cm 
of sawdust. Twenty-four hours before the test, we removed the food from the home cage. At the 
time of testing, a single pellet of food was placed on a square paper in the middle of the testing 
chamber. An animal was then placed in a corner of the box and the latency to eat the pellet was 
recorded within a 5 minute period. To evaluate this behavior in a time-dependent manner, the 
NSF test was performed 8, 11, 16 and 21 w after sciatic nerve surgery in independent sets of 
animals. For the optogenetic experiment, the NSF test was done directly after the inhibition 
procedure. 
 
Splash test 
This test was used to indirectly measure grooming behavior (3, 9). Duration of this behavior was 
measured for 5 minutes after spraying a 10% sucrose solution on the coat of the animals. 
Decreased grooming can be related to the loss of interest in performing self relevant tasks. To 
evaluate this behavior in a time-dependent manner, the splash test was performed on animals 11, 
14 and 16 w after the peripheral nerve injury in independent sets of animals. For the optogenetic 
experiment, the splash test was done during the inhibition procedure.  
 
Forced swimming test (FST) 
This test was done to evaluate despair-like behavior in neuropathic animals (525). We lowered 
the mouse into a glass cylinder (height 17.5 cm, diameter 12.5 cm) containing 11.5 cm of water 
(23-25 °C). The test duration is 6 minutes, but since only little immobility is observed during the 
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first 2 minutes, we only quantify the duration of immobility during the last 4 minutes of the test. 
We considered the mouse to be immobile when it floated upright in the water, with only minor 
movements to keep its head above the water. This test was performed 7, 14, 17 and 21 w after the 
sciatic nerve surgery in different sets of animals. 
 
Ex vivo electrophysiological recordings  
Mice were killed by decapitation and the brain was removed, then immediately immersed in cold 
(0-4°C) sucrose-based artificial cerebrospinal fluid containing (in mM): 2 Kynurenic acid, 248 
sucrose, 11 glucose, 26 NaHCO3, 2 KCl, 1.25 KH2PO4, 2 CaCl2 and 1.3 MgSO4 (bubbled with 
95% O2 and 5% CO2). Transverse slices (400 μm thick) were performed with a vibratome 
(VT1000S, Leica, Nussloch, Germany). Slices were maintained at room temperature in a 
chamber filled with artificial cerebrospinal fluid containing (in mm): 126 NaCl, 26 NaHCO3, 2.5 
KCl, 1.25 NaH2PO4, 2 CaCl2, 2 MgCl2 and 10 glucose (bubbled with 95% O2 and 5% CO2; pH 
7.3; 310 mOsm measured). Slices were transferred to a recording chamber and continuously 
superfused with artificial cerebrospinal fluid saturated with 5% O2 and 95% CO2. Pyramidal 
ACC neurons were recorded in the whole-cell configuration. Patch pipettes were pulled from 
borosilicate glass capillaries (Harvard Apparatus, Edenbridge, UK) using a P-1000 puller (Sutter 
Instruments, Novato, CA, USA). For optogenetic experiments performed in AAV5-CaMKIIa-
eArchT3.0-EYFP injected animals, pipettes were filled with a solution containing the following 
(in mm): 145 KCl, 10 HEPES and 2 MgCl2. For mIPSCs recordings, pipettes were filled with a 
solution containing the following (in mm): 75 Cs2SO4, 10 CsCl, 10 HEPES and 2 MgCl2.  The 
pH of intrapipette solutions was adjusted to 7.3 with KOH, and osmolarity to 310 mOsm with 
sucrose (3.5–4.5 MΩ). Recordings were performed in presence of CNQX (10 μM) and 
bicuculline (10 μM) for optogenetic experiments while mIPSCs were recorded with tetrodotoxin 
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(TTX, 0.5 µM) in the recording solution. For optogenetic experiments, the ACC was illuminated 
with the same system used for the in vivo experiments (see below) triggered with WinWCP 4.3.5, 
the optic fiber being localized in the recording chamber at 3 mm from the recorded neuron. For 
optogenetic experiments and mEPSC recordings, holding potential was fixed at −60 mV or at a 
holding current allowing maintaining the resting neuron at ca. -60 mV. For mIPSC recordings, 
the potential was fixed at 0 mV, corresponding to ECl in our experimental conditions. Recordings 
were acquired with WinWCP 4.3.5 (courtesy of Dr. J. Dempster, University of Strathclyde, 
Glasgow, United Kingdom). All recordings were performed at 34°C.  
In vivo electrophysiological recordings 
Animals were anesthetized in an induction box with a 2% isoflurane/air mixture (Vetflurane, 
Virbac) and after they were placed in a Kopf stereotaxic frame (KOPF 1730) equipped with a 
nose mask to continuously deliver the anesthesia. 
 A 1 x 1.4 mm cranial window was prepared directly anterior to bregma, ranging -0.7 to 0.7 
mm lateral from the midline. The dura was opened to lower the glass electrode in the brain. 
Recordings of spontaneous activity were performed using sharp electrodes pulled from 
borosilicate micropipettes (1.2 mm outer and 0.69 mm inner diameters, Harvard Apparatus, 30-
0044), with a Narashige pipette puller (tip diameter < 1 µm, resistance ±25 MΩ). The glass 
electrodes were filled with 0.5 M potassium acetate solution. The electrode signal was recorded 
through a silver wire, amplified with an operational amplifier (Neurodata IR-183A, Cygnus 
Technology inc.; gain x10), and then amplified further and filtered using a differential amplifier 
(Model 440, Brownlee Precision; gain x100; band pass filter 0.1-10kHz). The signal was then 
digitized with a CED digitizer (sampling rate: 20.8KHz) and recorded with Spike2 software 
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(Version 7.12b, Cambridge Electronic Design, Cambridge, UK). Raw data files were exported 
into Matlab and analyzed with custom Matlab scripts (Matlab 2015a). 
 During the recording procedure, isoflurane anesthesia was lowered to 0.5-0.75% and was 
monitored by regular paw pinching. The glass pipette was slowly lowered using a Scientifica one 
dimensional micromanipulator and recordings were done between 0.2 and 1.0 mm anterior to 
bregma ranging from -0.5 to 0.5 mm from the midline, which corresponds to layers 2/3 of the 
cortex. Neurons were recorded from the brain surface until 1500 µm deep. Once stable cell 
activity was detected, a 5 minute segment of spontaneous activity was recorded. Recording sites 
were marked by iontophoretically injecting a 4% Pontamine Sky blue dye (Sigma) in 0.5 M 
sodium-acetate solution (Sigma). At end of the recording, the mouse was perfused, the brain 
collected, and 40µm sections were cut on a cryostat. The position of  the recorded cells was 
registered using microdrive reference point with respect to the Pontamine Sky blue dye deposit. 
 
Single-Unit Analysis 
Spike detection and spike sorting were done using Spike2. Further single-unit analysis was 
performed using custom Matlab scripts (Version 2014a, Matworks inc.). Firing rate and bursting 
activity were calculated. Bursts were defined as 3 or more spikes within a 50 msec time window. 
Bursting activity was analyzed by calculating the total number of bursting events within a 90 
second data segment. The average number of spikes within a bursting event was also calculated. 
To assess the contribution of single spiking activity to the average firing rate, bursting events 
were artificially replaced by single spikes and firing rate was recalculated. Furthermore, cells 
were classified into four groups; regular single spiking, irregular single spiking, regular bursting 
and irregular bursting neurons.  
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Statistical Analysis 
Data are expressed as mean ± SEM. Prior to comparing samples, data was tested for normality. 
When data were not normally distributed, the Kruskal-Wallis test was performed followed by 
Mann-Whitney U post hoc tests to compare the means. When data were normally distributed, 
groups were compared with ANOVA multiple group comparisons followed by Duncan post hoc 
analysis, or with the student t-test. Significance level was set to p<0.05. Statistical analyses were 
performed with Matlab 2015a (Matworks inc.) and STATISTICA 7.1 (Statsoft, Tulsa, 
Oklahoma). 
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Results 
Inertia of affective and sensory symptoms of neuropathic pain 
It has been previously shown that the affective consequences of neuropathic pain evolve over 
time (3, 94, 97). Indeed, while mechanical hypersensitivity is immediately present following 
nerve injury, mice develop anxiety-related behavior 3-4 w later, while depression-related 
behavior is observed after 6-8 w (3). In the longer term, we show that the mechanical 
hypersensitivity recovers spontaneously around 12 w postoperation (PO) (F(47,308)=8.64, p<0.001, 
cuff<sham: 1
st
, 3
rd
, 5
th
, 6
th
 and 12
th
 w p <0.01, Fig. 4A). This raises the question of whether 
spontaneous pain and/or anxiodepressive consequences of chronic pain also recover or remain 
present. 
 To test the aversiveness of spontaneous pain, we performed the CPP test. Nerve injured 
animals displayed significant preference for the compartment associated with clonidine at 8 w PO 
(H(3)=10.73, p<0.015, cuff saline vs cuff clonidine  p<0.05), but also at 14 w PO (cuff saline vs 
cuff clonidine  p<0.05, Fig. 4C), despite the absence of mechanical hypersensitivity at this time-
point (Supplementary Fig. 1A). Interestingly, this preference disappeared after 22 w PO 
(H(3)=0.89, p>0.8, Fig. 4C), suggesting a recovery from spontaneous pain. 
 We then tested whether anxiodepressive-like behavior evolved simultaneously with the 
somatosensory or the aversive components of neuropathic pain. In the dark-light test, neuropathic 
pain increased anxiety-like behavior as shown by a reduction of time spent in the lit compartment 
at 8 w PO (p<0.001, Fig. 4G). This anxiety-like behavior disappeared after 15 w PO, which 
coincides with the recovery of mechanical allodynia. In contrast, the splash test showed less 
grooming behavior during both 11 w (p<0.01) and 14 w PO (p<0.01) (Fig. 4F) despite the fact 
that hypersensitivity was no longer present. This difference in provoked-grooming behavior 
disappeared at 16 w PO (Fig. 4C). Recovery from anxiodepressive-like behavior measured by the 
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Figure 4. Long-term behavioral consequences of neuropathic pain. (A)Cuff implantation induces an ipsilateral long-lasting 
mechanical hypersensitivity in C57BL/6J mice. After 3 months, mechanical thresholds returns back to sham levels spontaneously. 
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NSF test was delayed, for which increased latency to feed was present at 8 (p<0.001), 11 
(p<0.05), and 16 w PO (p<0.05), with recovery at 21 w PO (Fig 4E). The presence of depressive-
like behavior, as tested through FST, was also long-lasting. Indeed, nerve injured mice spent 
more time immobile, showing increased helplessness behavior at 7 (p<0.0001), 14 (p<0.01) and 
17 w PO (p<0.01) (Fig. 4D), which recovered only at 21 w PO (Fig. 4D). Together, these data 
show that some anxiodepressive consequences of neuropathic pain persist for over 2 months after 
the spontaneous recovery from mechanical hypersensitivity, which suggests that chronic pain / 
depression-like comorbidity follows a time course similar to the affective component of 
neuropathic pain rather than to its sensory component (Fig. 4B). 
 
ACC hyperactivity coincides with the emotional and anxiodepressive consequences of 
neuropathic pain 
ACC activity might be implicated in the anxiodepressive-like consequences of pain, since  ACC 
lesions prevent such consequences and optogenetic stimulation can induce depression-like 
behavior (9). Indeed, ACC neurons from nerve-injured animals have a significantly higher in vivo 
spontaneous firing rate and display an increased number of bursting events at 9 (p<0.01) and 16 
w PO (p<0.01, Fig 5B). Additionally, they show an increased number of action potentials per 
burst at 9 w PO (p<0.01, Fig. 5E). When classifying neurons in four categories (regular spiking, 
irregular spiking, regular bursting and irregular bursting), sham animals showed more irregular 
spiking neurons (Fig. 5F), while an increase in bursting neurons was observed in nerve-injured 
animals at 9 w PO (Fig. 5F). In the absence of anxiodepressive-like phenotypes, i.e. at 2 w PO 
(before affective symptoms develop) and at 23 w PO (after affective symptoms recovered), the 
firing rate or bursting activity remain similar between sham and peripheral nerve-injured animals 
(Fig. 5B). To evaluate whether ACC hyperactivity is a consequence of increased bursts only, we 
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replaced them with single action potentials, which showed that the increased firing rate is also 
caused by non bursting activity at 9 (p<0.01) and 16 w PO (p<0.01, Fig 5B).  
 Even though the cuff was placed on the right sciatic nerve only, there was no 
lateralization effect in terms of firing rate and bursting activity, whatever the considered time-
point (Supplementary Fig. 1D). 
 
Facilitation of excitatory synaptic transmission in the ACC coincides with emotional and 
anxiodepressive consequences of neuropathic pain 
To assess the impact of neuropathic pain on the synaptic transmission of pyramidal neurons, we 
recorded miniature synaptic currents at 8 w, when nerve-injured animals displayed depressive 
behavior. Both the frequency and amplitude of excitatory miniature synaptic currents (mEPSCs) 
(p<0.05, Fig. 6A) were significantly increased in nerve-injured mice, indicating facilitation of 
excitatory synaptic transmission onto pyramidal ACC neurons involving both pre- and 
postsynaptic changes. We did not find a change, however, in mIPSC frequency and amplitude in 
nerve-injured mice (Fig. 6B).  
 
Temporal inhibition of the ACC relieves the affective consequences of neuropathic pain 
Based on results demonstrating hyperactivity of the ACC in mice displaying anxiodepressive-like 
behavior, we studied whether the optogenetic temporal inhibition of the ACC may counteract 
these consequences. 
 The delivery of AAV5-CaMKIIa-eArchT3.0-EYFP resulted in reliable virus transfection 
in the ACC, which was confirmed by evaluation of EYFP fluorescence in the target structure 
(Fig. 7A). In order to characterize the effect of green laser light illumination on transfected ACC 
neurons, we performed ex vivo electrophysiological recordings. Patch clamp recordings showed 
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that illumination with green light inhibits action potential firing reliably, by inducing an inward 
current (Fig. 7B). 
 In vivo, our results demonstrate that mechanical hypersensitivity was not affected by ACC 
inhibition (p<0.05) (Fig. 7C). However, inhibition of the CaMKIIa ACC neurons induced a place 
preference in cuff implanted animals at 8 w PO (i.e. when hypersensitivity is still present) 
(H(3)=9.45, p=0.02, cuff stimulated vs cuff control p <0.05) (Fig. 7D), as well as at 14 w PO (i.e. 
when hypersensitivity spontaneously recovered) (H(3)=11.54, p=0.009, cuff stimulated vs cuff 
control p<0.05) (Fig. 7D; Supplementary Fig. 1E); without affecting sham animals. These 
findings support the idea that inhibition of the ACC relieved the aversiveness of spontaneous pain 
in nerve-injured mice. 
 Finally, we show that the optogenetic inhibition of the ACC also suppressed the 
anxiodepressive phenotype in nerve-injured animals, as observed by a normalization of grooming 
duration in the splash test (Fig 7E) and latency to eat in the NSF test (Fig. 7F). Unstimulated 
nerve-injured animals, however, did still show the characteristic phenotypes (sham control vs 
cuff control p<0.05, Fig. 7E, F). 
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Discussion 
In the present study, we show that different symptoms of neuropathic pain, including evoked 
hypersensitivity, aversiveness of spontaneous pain and anxiodepressive-like consequences, are 
segregated in a time-dependent manner since they develop and cease at different time points after 
nerve injury. The in vivo electrophysiological recordings show ACC hyperactivity, which 
coincides with the time window of pain aversion and anxiodepressive-like behavior. Ex vivo 
patch clamp recordings further support ACC hyperactivity, as shown by increased excitatory 
synaptic transmission. Finally, our results show that temporal inhibition of the ACC hyperactivity 
can alleviate the aversive and anxiodepressive aspects of neuropathic pain. 
 A growing number of clinical and preclinical studies show that the comorbidity of chronic 
pain and mood disorder changes over time (3, 4, 9), which raises the question of whether the 
various symptoms of neuropathic pain are interdependent or develop separately. While animals 
develop mechanical hypersensitivity immediately after the nerve injury, they spontaneously 
recover from this symptom after 3 months, which allows for the study of the behavioral 
consequences of neuropathic pain in the presence and absence of hypersensitivity. Patients with 
chronic pain usually experience spontaneous or ongoing pain also, which is rarely evaluated in 
preclinical studies. In animals, this symptom can be unmasked by alleviating the pain-related 
tonic aversive state in a CPP procedure (9, 513). For instance, injection of lidocaine into the 
rostral ventromedial medulla, a brain area that mediates descending modulation of pain (526), or 
spinal injection of clonidine (9, 513), induce place preference only in nerve injured animals. In 
this study, we detected the presence of spontaneous pain until 22 w, i.e. over 2 months after 
hypersensitivity disappeared, which is the first pathophysiological evidence of naturally-
occurring dichotomy between evoked hypersensitivity and spontaneous pain in an animal model. 
The hypersensitivity and the spontaneous pain that follow nerve injury have been proposed to 
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share some mechanistic features. Indeed, both may imply an upregulation of voltage gated 
Nav1.8 channels in primary afferent neurons (527), an alteration of descending pathways (526) 
and of spinal NK-1 positive ascending projections (528). However, studies also point out that 
they can be distinguished mechanistically as well as neuroanatomically. Indeed, the lesion of the 
ACC can block the aversiveness of spontaneous pain in both neuropathic (9, 514) and 
inflammatory pain (492) models without affecting mechanical hypersensitivity (5,15, 17); while 
the lesion of the posterior insular cortex can suppress the maintenance of mechanical 
hypersensitivity (9, 529) without affecting spontaneous pain (9). In addition, large-diameter 
fibers of the dorsal column were proposed to mediate mechanical hypersensitivity but not 
spontaneous pain (528). This dichotomy should thus be taken into consideration for drug 
development, since evoked hypersensitivity, rather than spontaneous pain, is presently used for 
target validation. As it is more often spontaneous pain that leads patients to seek treatment, this 
may in part explain why the development of new treatments has not always provided translational 
satisfaction. 
 While mechanical hypersensitivity is no longer present after 3 months, we still observe 
aversive and depressive-like behavior until 22 weeks. Previously, it has been reported in rats that 
anxiodepressive-like behavior persists at least 2 weeks after normalization of mechanical 
sensitivity following cuff removal (517). However, longer term consequences were not 
addressed.  Our results in mice confirm and further extend this sensory/affective dichotomy by 
showing that depressive-like symptoms persist more than 2 months after cessation of 
hypersentivity. However, we also show that recovery from anxiety-like behavior is faster and 
coincide with the disappearance of mechanical hypersensitivity. It is then possible to hypothesize 
that anxiety-like behavior may be associated with the somatosensory component of chronic pain, 
while depressive-like aspects are caused by the aversive state induced by spontaneous pain. 
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These prolonged emotional consequences thus point out the presence of long-term plastic 
changes in the brain, secondary to a peripheral nerve injury. One of the cortical regions where 
such morphological (47, 522) and functional plasticity (391, 521) has been reported is the ACC.  
 In this study, in vivo single unit extracellular recordings evidenced increased activity of 
the ACC at 9 and 16 week PO, which coincides with aversive and depressive-like behavior. In 
humans, fMRI studies have shown that the ventral part of the ACC, which is involved in 
emotional processing (249), is hyperactive in depressed patients (315, 316), and that activity 
patterns in ACC subregions correlated with symptom clusters such as sadness and depressed 
mood (315). This role is further supported by an animal study showing increased cingulate 
activity, as shown by c-Fos overexpression, accompanied by depressive-like behavior in a social-
defeat-paradigm (356). Such hyperactivity may rely on alterations in neurotransmitter systems, 
such as an imbalance between excitatory and inhibitory transmission (47). Indeed, a loss of 
inhibitory synapses onto excitatory pyramidal neurons, and a loss of the excitatory drive unto 
inhibitory fast-spiking interneurons, have been proposed to underlie local disinhibition of the 
cortical network in a context of neuropathic pain (47). This disinhibition might explain the 
increased activity observed in the ACC of patients with nerve injury (67). Studies from the 
depression field further support this imbalance. Indeed, Northoff and Sibille (318), hypothesized 
that abnormal ACC activity in depression can be associated with changes in GABA interneurons. 
Indeed, somatostatin (341) and parvalbumin levels (342), neuropeptides expressed in GABA 
neurons, are low in patients with major depressive disorders  (318). Our data show that ACC 
hyperactivity observed in neuropathic pain-induced depressed animals might also be linked to 
long-term increase in excitatory synaptic transmission.  
To leap from correlative analyses to a causal link between the ACC hyperactivity and 
behavioral outputs of neuropathic pain, we performed optogenetic inhibition of the ACC. We 
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show that the inhibition of the ACC suppresses the aversiveness of the spontaneous pain and 
depressive-like consequences of neuropathic pain without affecting the mechanical 
hypersensitivity. These results further reinforce the sensory/affective dichotomy, as well as the 
links on one hand between pain aversiveness and depressive-like consequences, and on the other 
hand between ACC hyperactivity and these affective aspects of chronic pain. 
 In conclusion, our results emphasize that mood disorders comorbid with chronic pain are 
temporally segregated from the evoked hypersensitivity whereas they follow the same time 
course as the aversiveness of spontaneous pain. This should be taken into consideration to 
improve the translational feature of preclinical models, and for preclinical target validation of 
relevant potential therapies. The fact that the emotional aspects of chronic pain are driven by 
ACC hyperactivity further highlights the ACC and its circuitry as critical neuroanatomical 
substrates to further explore mood disorder mechanisms.   
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General discussion 
In the next section, we first discuss the methodological considerations of the cuff model, 
excitotoxic lesions, electrophysiology and optogenetics. In the second part, we discuss the results 
of two papers in a broader perspective.  
I. Methodological considerations 
Modeling neuropathic pain can be done in a variety of ways. For a number of reasons we chose 
the approach as described in the previous chapters.    
A. Cuff model: modeling neuropathic pain in rodents  
Even though neuropathic pain includes both somatosensory and emotional components, most 
preclinical studies focus on mechanical allodynia since it’s the easiest symptom to evaluate in 
rodents. The most frequently used approach to evaluate mechanical allodynia is using von Frey 
filaments which helps evaluate static mechanical allodynia by applying static pressure on a single 
point of the hindpaw. In the clinic however, dynamic mechanical allodynia is usually measured 
by brushing a cotton bud or brush against the affected area (530). While it is possible to measure 
dynamic mechanical allodynia in rats, even though it is not well characterized (531), it is very 
challenging to adapt this method in mice since they are more active and their paws are too small 
to be reliably stimulated with a brush. Therefore, in this study, we mainly used von Frey 
filaments.  
In our model, mechanical allodynia is observed from the first day until 3 months after 
surgery. Interestingly, cuff implanted animals spontaneously recover from mechanical allodynia 
after 3 months. Although reasons as to why this happens are of yet unclear, possible mechanisms 
at the level of the nerve, spinal and supraspinal areas could potentially provide an explanation. 
For instance, one cause of neuropathic pain is the loss of peripheral neurons caused by injury or 
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metabolic disease such as diabetes. Therefore, recruitment of cellular survival strategies which 
prevent neuronal apoptosis such as synaptic remodeling, and remyelination can all 
counterbalance the loss of neuronal input that normally accompanies peripheral neuropathic pain 
(532, 533). In addition, ectopic activity in primary sensory neurons by the increased translation 
and trafficking of receptors and ion channels under the influence of neurotrophic factors also 
contribute to increased sensory sensitivity (36). Therefore, receptor endocytosis or a reduction of 
receptor trafficking can potentially underlie the recovery from mechanical allodynia in our 
model. On the other hand,  nerve injury has been shown to induce an immune response by 
recruiting immune cells including macrophages and lympocytes (534) and by increasing 
proinflammatory cytokines (534) which have been shown to increase excitability (535, 536). 
Therefore, decrease of proinflammatory cytokines could further decrease the excitability of 
peripheral nerves and lead to decreased mechanical hypersensitivity. 
At the spinal level GABAergic inhibition is reduced after nerve injury which could be due to 
an decrease inhibitory neurons (40, 42) or due to a decrease of input from peripheral excitatory 
peripheral neurons which decreases excitability or burst firing pattern of GABAergic neurons 
(537). Therefore, recovery of GABAergic activity might reduce neuropathic symptoms (40, 42, 
537). 
Finally, supraspinal descending control could contribute to the recovery from mechanical 
allodynia. Serotonergic and adrenergic innervation from the antinociceptive pathway which 
includes the rostral ventromedial medulla (538, 539), the dorsal raphe nucleus (539) and the locus 
coeruleus (539) has been shown to induce GABA release in the spinal dorsal horn (540) which 
reduces excitability. A potential mechanism might lie in the increase sprouting of descending 
fibers as it has been shown that nerve injury induces spinal BDNF which in turn increases the 
amount descending noradrenergic fibers that originate from the locus coeruleus (541). 
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Besides mechanical allodynia, hyperalgesia is another common symptom of neuropathic pain. 
Previous studies have shown that hyperalgesia exists during the first 15 days after cuff surgery 
and can be tested with the “Radiant heat paw-withdrawal test” (8). Considering that the aim of 
our studies was to expose the long-term consequences of neuropathic pain, this test would not 
have been of much of our interest.  
Even though spontaneous pain is a more debilitating symptom than the evoked 
nociceptive response in neuropathic pain patients, it remained elusive in preclinical studies. 
Methods to examine spontaneous pain in mice include the use of mouse facial expressions, 
vocalizations and conditioned place preference. In the next part I will provide the advantageous 
and disadvantageous for each of these techniques. 
The monitoring of facial expression of mice has been proposed as a potential to measure 
spontaneous pain (542) in which a three point scale is used to distinguish five facial features 
(542, 543). A major advantage of this technique is that spontaneous pain can be measured several 
times and directly without any intervention. However, it seems to be mandatory that white 
animals with red eyes are used as the lack of contrast on an overall black animal make the 
recording of facial features too difficult. For this reason there are, as of now, no studies published 
using this technique on non-white coated animals (544). Considering that this method is not well 
standardized in mice, we could not use facial expressions to monitor spontaneous pain. 
Another proposed technique to directly measure spontaneous pain is the use of rodent 
ultrasound vocalization (USV). USVs are recorded as they are found more consistently during 
acute application of nociceptive stimuli (544)  in contrast to audible vocalizations. However, 
whether USV communication is directly linked to pain is unclear as the majority of studies failed 
to measure USVs in chronic pain models (544). A major disadvantage of this technique are the 
74  
 
fact that, in order to measure USVs, the mouse has to be placed in a mouse holder which can 
cause stress (545) and therefore cause problems in detecting stimuli dependent USVs. Other 
problems are the sensitivity to background noise, which can cause false positive detection, and 
the lack of standardization. Variations in vocalization frequencies due to age, animal strain and 
sex and the use of different frequencies and recording techniques by different groups all cause 
difficulties in standardizing this technique (544). 
In this thesis work, spontaneous pain was measured by performing the CPP test in which 
the preference of the compartment coupled with an intrathecal injection of a non-rewarding 
analgesic (clonidine) is an indirect measurement for the presence of spontaneous pain. CPP is due 
to the rewarding effects of pain relief as well as the aversive effect of spontaneous pain. In rats, 
the analgesics could be injected through a permanently implanted catheter (513) which allows 
successive injections in animals without causing pain due to the injection needle. In mice, 
however, the space between vertebras is too small to allow the placement of a catheter. 
Additionally, placing the catheter takes a lot of time and injecting the analgesic through this 
method can damage the spinal cord which impairs the possibility of retesting.  
CPP has been validated substantially in the literature (3, 9, 544) and can be done semi-
automatically with the use of automated CPP testing chambers. A disadvantage of this test is that, 
as we use the indirect measure of preference, the test is highly dependent on memory which 
means that lesioning of inhibition of a brain region related to memory could impair the test 
results. Finally, it is likely that animals feel pain due to entering of injection needle, however, this 
confound is possibly nullified by the use of a sham injection group as they show no preference 
for the clonidine coupled compartment.  
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B. Excitotoxic lesion: Permanent ablation 
In order to initiate the project we needed a global understanding of the role of the pIC and the 
ACC in neuropathic pain-induced depression. For this reason we decided to start the project with 
a global ablation by using ibotenic acid. Our results show that the role of the ACC and pIC are 
functionally distinct. For instance, lesioning the pIC blocked the maintenance of mechanical 
allodynia whereas the ACC is critical for the emotional component and anxiodepressive 
consequences of neuropathic pain. Caution should be taken however, with oversimplification of 
the results. For instance, the ACC as well as the pIC are heterogeneous regions which can be 
divided between dorsal and ventral or agranular, granular and dysgranular, respectively. The 
lesioning technique used in our study lacks the precision to cater to such anatomical nuances, 
especially when the region is not clearly delimited as is the case with the IC. Two other 
disadvantages of excitotoxic lesioning are that the brain is lesioned indiscriminately of cell type 
and permanently. In order to gain cell type specificity and inhibit the ACC temporarily, we 
designed an experiment using optogenetic inhibition which will be discussed in part IV of this 
chapter.   
 Even though our results suggest a segregation of functions of these regions, we should keep 
in mind that the ACC and the pIC project to each other and project in part to the same brain 
regions. Therefore, one might suggest that the lesion of either of these regions influences the 
other either by direct or indirect connectivity. 
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C. Considerations of electrophysiological recordings under anesthesia 
The main debate surrounding our electrophysiological experiments involves the use of 
anesthetics. In our study, we performed our electrophysiological recording under isoflurane 
anesthesia which has been shown to decrease regional activity in cortical brain areas (546, 547). 
Besides its main effect on the voltage gated sodium channels, isoflurane’s anesthetic properties 
are, at least partly, caused by its enhancing effects on postsynaptic GABA-A receptor gating in 
the presence of submaximal GABA concentrations (548). Isoflurane also increases Ca
2+
 release 
from intracellular stores, which facilitates the release of GABA and activates Ca
2+
 dependent K
+
 
channels, and inhibits voltage-gated Na
+
 channels, all of which reduce neuronal excitability 
(549). An fMRI study showed that isoflurane decreases the amplitude of low frequency 
fluctuations (ALFF), which is a measurement of spontaneous regional activity at rest, in a 
number of regions including the somatosensory cortex and the thalamus (547) which further 
supports the inhibitory role of isoflurane. Additionally, they found that functional connectivity in 
the cortico-thalamo-cerebellar circuit and sensory areas was reduced. Although these structures 
are part of the pain matrix and provide input to the ACC, no difference in ACC activity or 
functional connectivity was reported under the influence of isoflurane. On the other hand, in this 
study besides the induction period, the isoflurane administered less than 1% in which no 
significant EGG alterations was observed (data not shown). Accordingly, follow up studies in 
awake as well as in freely moving animals can help us to confirm the role of the ACC in 
neuropathic pain condition and to correlate the electrophysiological recordings with the 
behavioral alterations.     
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D. Optogenetics: cell specific temporal excitation and inhibition  
Optogenetic is a technique that allows cell specific excitation or inhibition. In order to stimulate 
the ACC, we used Thy1-ChR2-YFP mice which express ChR2-YFP in Thy1 expression neurons. 
What should be noted is that; all neurons that express Thy1 also express vGlut1 and CaMKII 
however only a subset of neurons expressing vGlut1 or CaMKII express Thy1 (550). This means 
that optogenetic stimulation of ChR2-YFP containing neurons stimulates glutamatergic neurons 
however not all glutamatergic neurons are stimulated. 
For optogenetic inhibition of the ACC we used a transfection method by injecting AAV5-
CaMKIIa-eArchT3.0-EYFP into the ACC. This genetic construct allows the expression of 
inhibitory opsin eArchT3.0 coupled to yellow fluorescent protein. CaMKIIa is present in 32-35% 
of all cortical neurons and is only present in glutamatergic cells (551, 552). 
A major advantage of optogenetics is that it allows for temporary excitation or inhibition of 
specific neurons and the coupling with the YFP allowed us to check whether the viral transfection 
was in the right location. A disadvantage, however, was that our glass cannulas were too big to be 
implanted bilaterally. For this reason, left and right side implantations were divided equally 
among all experimental groups. Verification of c-Fos expression showed that even though 
implantation was unilateral, expression of c-Fos was bilateral (9). This could be due to the light 
reaching from one hemisphere to the other.  
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II. Functional differentiation between the ACC and pIC 
The aim of our first study was to elucidate the ACC’s and pIC’s roles in the affective and sensory 
components of neuropathic pain as well as in the neuropathic pain mood disorder comorbidity. 
Our lesioning results show that the pIC is essential for the sensory component of chronic pain 
whereas the emotional as well as the anxiodepressive component depends on the ACC. ACC 
stimulation helped to further support this notion, as ACC stimulation in naive mice led to 
anxiodepressive-like behavior.  
 Many previous studies have implicated the ACC in depression (see chapter V). The 
dACC has been shown to be hypoactive in depressed patients whereas the vACC has been shown 
to be hyperactive (553). A preclinical study, using the social-defeat paradigm further confirmed 
ACC hyperactivity in an animal depression model. In the present work, we showed that 
optogenetic ACC stimulation can induce anxiodepressive-like behavior which persists several 
days after the end of the stimulation and that ACC inhibition in neuropathic mice alleviates 
anxiodepressive behavior. Together this further suggests that anxiodepressive –like behavior is 
triggered by a sustained disadaptation of the affective system not the somatosensory system, even 
in the presence of neuropathic pain.  
The pIC has been shown to play a role in the processing of pain intensity information 
(554, 555). This was further confirmed in our studies which showed that pIC lesioning had no 
effect on the aversiveness of spontaneous pain and anxiodepressive consequences but did 
alleviate mechanical allodynia, showing that that the pIC is not involved in the affective 
component of chronic pain but is involved in the sensory component especially the maintenance 
of mechanical allodynia.  
Some studies relate the IC with anxiety and depression (556, 557). However, this 
discrepancy might underlie methodological differences as the mentioned studies either study 
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acute pain (555) instead of chronic pain or target a different IC subregion. This notion is 
supported by studies indicating that not the pIC but the anterior IC, which was studied in (556), is 
involved in cognition/emotion related processing whereas the pIC is involved in somatosensory 
processing (558, 559).  
 
III.  ACC hyperactivity and neuropathic pain mood disorder comorbidity 
Our in vivo electrophysiological recordings show ACC (24a/24b) hyperactivity when animals 
with peripheral nerve injured display aversive as well as anxiodepressive-like behaviors. In MDD 
patients, a number of studies showed that ACC hyperactivity is in part caused by a reduction of 
GABAergic activity which in turn causes a shift in excitation/inhibition balance which causes 
increased perigenual ACC activity (336, 560, 561). The perigenual ACC is part of the default 
mode network (DMN) and has been shown to have a negative reciprocal connection with the 
DLPFC (562), which is part of the executive network (561, 563). Activity changes in the DMN 
and executive networks have been hypothesized to underlie depression symptoms such as 
excessive worrying (564-566).  
The executive network is responsible for cognitive-executive functions including generation 
of goal-orientation and the processing of external stimuli stemming from exteroceptive sensory 
inputs (567). The DMN however, has been associated with various inner mental functions like 
mind wandering (568, 569), undirected thoughts (570), consciousness (571, 572) and, most 
importantly, self-referential activity (573-575). Increase in the DMN/ perigenual ACC causes a 
decrease in the executive network / DLPFC which directs the mental awareness towards internal 
content which causes excessive brooding, rumination and increased self-referential processing in 
MDD patients (564-566). 
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Another MDD symptom is anhedonia; the loss of interest or pleasure in previously rewarding 
activities (American Psychiatric Association, 2013). Anhedonia is characterized by decreased 
responsiveness of the mesocorticolimbic reward circuitry (576-578). As a part of this circuitry the 
ACC plays a role in detecting the salience of external stimuli and in reward feedback monitoring 
(579, 580) by altering dopamine release in the VTA in order to direct behavior towards rewarding 
or away from harmful stimuli (581). ACC hyperactivity therefore, could alter its influence on the 
VTA by decreasing dopamine release and cause anhedonic behavior by decreasing the urgency of 
a rewarding stimulus.  
The ACC also modulates the generation of fear by integrating sensory and affective 
information (582). Hyperactivity of the ACC could be responsible for the generation of anxiety in 
the neuropathic pain condition since projections between the ACC and BLA have been shown to 
be glutamatergic (583). Additionally, a recent study showed that pain-related hyperactivity of the 
BLA plays an important role in emotional-affective aspects of pain (584).  
In our study the inhibition of the ACC resulted in the alleviation of depressive-like symptoms. 
As has been mentioned before, depression symptoms are often associated with an 
excitatory/inhibitory imbalance. Therefore, we propose that inhibition of the structure could be a 
potential way to treat depression. Inhibition of the ACC can be accomplished through a number 
of ways. DBS uses electrical stimulation which has been hypothesized to inhibit through; creating 
a depolarization block, inactivate voltage-gated currents or activation of inhibitory afferents 
(585). Indeed ACC-DBS has been used successfully in the treatment of both neuropathic pain 
(446) and depression (324, 586). Another way to alter the excitatory/inhibitory balance is through 
the use of drugs that act on glutamergic systems. A wide range of antidepressive agents have 
shown to reduce glutamatergic action through competitive NMDA antagonism or blockage such 
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as; phencyclidine, dizocilpine and ketamine (587) . However, increasing GABAergic activity 
through drugs, such as benzodiazepines, in order to skew the excitatory/inhibitory balance 
towards inhibition did not alleviate depression symptoms in most studies (588).  
IV. Perspectives 
Future work should focus on expanding our techniques and direct focus towards a more 
computational approach in order to gain a clearer picture of what ACC hyperactivity really 
constitutes. As mentioned before, future work done in awake animals could further deepen the 
understanding of the ACC’s contribution in anxiodepressive-like behavior and affective 
processes by allowing recordings during behavioral tasks. In turn, computational methods could 
use ACC activity in order to predict animal behavior. 
Additionally, using permanently implanted electrodes will allow us to record, and 
differentiate between, multiple neurons simultaneously. In turn, this could allow us to correlate 
single-unit activity between different cells in the same and other cell layers in order to generate 
an ACC network model of affective and emotional processing. This is important because 
“hyperactivity” is likely only a symptom of an underlying meaningful change of processing 
within the broader network of the ACC. By doing recordings of a single neuron at a time, we 
miss this underlying information. 
 Performing in vivo electrophysiological recordings and optogenetics simultaneously could 
provide a lot of information. For instance, network analysis could be done by exciting or 
inhibiting the ACC and recording activity in output regions such as the BLA. When using 
permanently implanted electrodes all three of these facets (behavior, electrophysiology and 
optogenetic stimulation) can be combined and provide a more complete understanding of 
hyperactivity, network connectivity and behavioral consequences.       
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Jim SELLMEIJER 
 Le cortex cingulaire antérieur : une structure 
clé dans les conséquences émotionnelles de la 
douleur neuropathique 
Résumé 
Outre le stress chronique, la douleur chronique représente une cause majeure de dépression. En 
effet, environ 50% des patients qui souffrent d’une douleur chronique développent des troubles 
de l’humeur. Les perturbations des structures cérébrales impliquées dans la perception de la 
douleur pourraient contribuer à cette comorbidité, dont les mécanismes restent pourtant mal 
compris. Nous avons étudié l’implication du cortex cingulaire antérieur (CCA) dans les 
conséquences sensorielles et émotionnelles de la douleur neuropathique dans un modèle murin. 
Nous avons montré qu’une lésion du CCA ou une inhibition des neurones pyramidaux du CCA 
préviennent l’émergence des désordres émotionnels dans notre modèle. De plus, nos résultats 
indiquent que ces conséquences émotionnelles coïncident avec une hyperactivité neuronale dans 
le CCA. En conclusion, nous montrons que le CCA est une structure clé pour la dépression 
induite par la douleur neuropathique. 
 
Résumé en anglais 
Besides chronic stress, chronic pain is one of the prevalent determinants for depression. Indeed, 
around 50% of chronic pain patients develop mood disorders. Alterations in brain regions 
implicated in pain processing may also be involved in affective processing, thus potentially be 
responsible of mood disorders. However, the underlying mechanisms of this comorbidity are not 
yet elucidated. Here, we studied the role of the anterior cingulate cortex (ACC) in the 
somatosensory, aversive and anxiodepressive consequences of neuropathic pain. We showed that 
a permanent lesion or temporal inhibition of ACC pyramidal neurons blocked the development or 
suppressed the expression of an anxiodepressive phenotype in neuropathic mice. In addition, 
anxiodepressive-like behavior coincided with ACC hyperactivity. In conclusion we show that the 
ACC is a critical hub for neuropathic pain-induced depression.   
 
 
 Jim Sellmeijer 
Geerdinkhof 331, 1103RB Amsterdam, Netherlands 
Telephone: +33652880058 Email: jimsell@gmail.com 
Date of birth: March 14, 1989   Nationality: Dutch Gender: Male 
 
Recent employment history  
Joint PhD program at the Universities of Strasbourg, Freiburg and Basel, 2013-2016 
Three-year full-time 
My responsibility was to research how neuropathic pain elicits activity changes in the 
Anterior Cingulate Cortex and why this leads to depression. I designed and conducted 
experiments in order to perform electrophysiological recordings and I used genetic 
manipulations to alter cellular machinery that changed regional activity. In order to 
automate the extensive analysis I wrote software in Matlab.   
 
Practical course supervisor at the University of Amsterdam 2012-2013 
1 year part-time 
My responsibility was to teach 1st and 2nd year biomedical science students practical 
research skills such as electrophysiological recording and data analysis. 
 
Education  
MSc Brain and Cognitive Sciences: Neuroscience, University of Amsterdam 2010-2012  
Two-year full-time  
A Research Master’s program with a strongly biologically oriented approach to 
neuroscience. The program consisted out of half a year of courses and fifteen months of 
research internships.  
 
BSc Psychobiologie, University of Amsterdam 2007-2010  
Three-year full-time  
Bachelor’s program with a main focus on the biology of the brain. The final year was 
concluded with a five month internship.  
Third year track: Cell Biology  
 
Relevant skills  
Computer skills: Matlab programming: Proficient 
   C# programming: Proficient 
Unity 5: Proficient 
Game design: Experienced 
MS Excel: Proficient  
SPSS: Experienced  
 
Scientific skills:  Big data analysis: Proficient 
Optogenetic stimulation in behaving animals: Proficient 
   Genetic modification through virus injections: Proficient 
Electrophysiological recordings & analysis: Proficient 
fMRI recordings & analysis: Proficient 
   Behavioral animal studies: Proficient 
 
Languages:   Dutch: Native  
English: Fluent in speaking, listening, writing and reading  
Afrikaans: Fluent in speaking, listening, writing and reading 
German: Control in speaking, listening, writing and reading 
French: Control in speaking, listening, writing and reading  
 
Academic achievements 
Research Fellowship  
In 2013 I was awarded the Erasmus Mundus NeuroTime fellowship which helped funding my PhD 
research for 3 years. 
 
Scientific Publications  
Sellmeijer J, Hugel S, Barthas F, Karatas M, Luthi A, Veinante P, Barrot M, Aertsen A, Yalcin I  
(Anterior Cingulate Cortex hyperactivity drives chronic pain-induced depression). In 
revision.  
 
Barthas F, Sellmeijer J, Hugel S, Waltisperger E, Barrot M, Yalcin I (The anterior cingulate cortex is 
a critical hub for pain-induced depression. Biol Psychiatry 77:236-245.2015). 
 
Bleichner MG, Jansma JM, Sellmeijer J, Raemaekers M, Ramsey NF (Give me a sign: decoding 
complex coordinated hand movements using high-field fMRI. Brain Topogr 27:248-
257.2014). 
 
Oostland M, Sellmeijer J, van Hooft JA (Transient expression of functional serotonin 5-HT3 
receptors by glutamatergic granule cells in the early postnatal mouse cerebellum. J Physiol 
589:4837-4846.2011). 
 
Published Abstracts 
Sellmeijer J, Barthas F, Barrot M, Aertsen A, Veinante P, Yalcin I (Electrophysiological changes in 
the anterior cingulate cortex in neuropathic pain-induced depression, SFN 2015) 
 
Sellmeijer J, Barthas F, Barrot M, Veinante P, Yalcin I (The anterior cingulate cortex is a critical 
hub of the anxiodepressive consequences of neuropathic pain, NEUPSIG 2014) 
 
 
Hobbies and personal interests 
Software and game design 
In my spare time I take great pleasure in developing android apps and games. My games are made 
with the Unity engine and scripts are written in C#.   
 
LinkedIn: http://www.linkedin.com/pub/jim-sellmeijer/48/760/850 
